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Although it has been recognized for decades that fat ingestion is associated with an acute increase 
in the plasma triglyceride pool size {1 ), the factors which determine the magnitude of the postprandial 
plasma triglyceride excursion remain poorly understood. Several investigators have sought to deter-
mine the importance of postprandial lipemia in the pathogenesis of atherosclerosis {2-4), but the 
physiological factors which influence postprandial plasma triglyceride concentrations have received lit-
tle study. An early, but comprehensive review of the literature by Angervall (5) included fewer than 15 
references to the topic. The paucity of systematic investigations into the regulation of postprandial 
triglyceride metabolism has also been noted in a recent review by Tall {6). The work described in this 
thesis was accordingly undertaken to identify factors which may play a role in the acute regulation of 
postprandial plasma TG concentrations. The thesis comprises a series of related but independent chap-
ters, each of which describes an investigation into the putative role of one such factor. Each c~apter 
includes a review of the appropriate literature, an explanation of why the experiment was undertaken, 
a description of methods and results, and a discussion of the results in the context of current knowledge. 
To minimize redundancy, the laboratory and clinical procedures used throughout the study have been 
described in detail in the chapter entitled "General Methodology•. 
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ABSTRACT 
The regulation of the serum triglyceride responses to fat ingestion have been examined in nor-
molipidemic men. To evaluate the existing methods for comparing chylomicron-triglyceride clearance, 
the oral and intravenous fat tolerance tests and a steady state duodenal perfusion method were com-
pared. Good correlations (r > 0.8) were found between each of these methods. Since the intravenous 
fat tolerance test is independent of fat absorption, these data suggested that the serum triglyceride 
response to fat feeding was largely determined by the rate of chylomicron-triglyceride clearance. To 
determine the influence of the quantity and type of meal fat on postprandial serum triglyceride con-
centrations, the serum triglyceride responses to three different doses of dairy cream, and to standard 
doses of olive and sunflower oil were examined. For a given type of fat, the magnitude of postprandial 
lipemia (the integrated serum triglyceride excursion) varied directly with the quantity of fat in the meal. 
This finding suggested that the chylomicron- triglyceride clearance system(s) did not become sat~rated 
even after large fat meals. In addition, it appeared that the hormonal factors released in response to fat 
ingestion (some of which are known to increase lipoprotein lipase activity in vitro) did not increase the 
rate of chylomicron-triglyceride clearance. If the quantity of fat in a meal was fixed, then postprandial 
lipemia increased with increasing saturation of the triglyceride fatty acids. These differences did not ap-
pear to reflect differences in triglyceride absorption. 
Since acute fat feeding per se did not appear to stimulate chylomicron-triglyceride clearance, the ef-
fects of dietary proteins and carbohydrates were studied. The addition of up to 35g protein to a stand-
ard test meal did not affect postprandial lipemia. These results were supported by the observation that 
protein ingestion did not affect intravenous fat tolerance. 
Postprandial serum triglyceride concentrations were significantly influenced by carbohydrate inges-
tion. Fructose (50g) and sucrose (1 OOg) markedly increased postprandial lipemia, although glucose in-
gestion did not. In agreement with earlier studies, glucose ingestion decreased serum triglyceride 
concentrations 2 hours after the meal. This effect was abolished by intraduodenal fat administration 
and by substituting starch for glucose in the test meal. The effects of glucose could be reproduced by 
iso-osmotic quantities of urea, however. These findings suggested that glucose ingestion did not in-
crease chylomicron-triglyceride clearance. It is more likely that glucose delayed the absorption of 
triglycerides by slowing gastric emptying, and that this effect was partly related to the incr_eased os-
molarity of glucose- containing meals. 
The effects of chronic exercise on postprandial lipemia and chylomicron-triglyceride clearance were 
determined in endurance- adapted athletes. The serum triglyceride responses to large and small fat 
meals were lower in athletes than in sedentary men with comparable fasting triglyceride concentrations. 
These differences were not eliminated by a single bout of acute exercise in the sedentary men. The 
clearance of intravenously administered lntralipid, and chylomicron-triglyceride clearance assessed 
from steady state chylomicron-triglyceride concentrations during duodenal fat perfusion were faster in 
athletes than in the sedentary men. These data suggested that the low postprandial lipemia in athletes 
reflects increased chylomicron-triglyceride clearance caused by increased activity of the triglyceride 
clearing system(s) . 
Given these considerations. it appears that the pathway(s) for chylomicron triglyceride clearance are 




In men consuming Western diets, fats comprise some 40% of the daily caloric intake (7) . The bulk of 
these fats {90%) are ingested as long-chain triglycerides (TG), containing primarily C16 and C18 fatty 
acids (8,9). Other lipids such as cholesterol and phospholipids generally contribute less than 10g to 
the total weight of the diet. Accordingly, a Western man consuming 3000 Calories per day ingests some 
130g fat daily, of which approximately 120g is TG. 
Digestion and absorption of dietary triglyceride: 
The digestion and absorption of TG has been extensively studied, and several reviews of the topic 
have been published. A brief description of the absorptive processes is presented here. For more 
detailed information the reader is referred to reviews by Friedman (10), Carey (11 ), and Tso (12,. 
Triglyceride digestion comprises 3 sequential steps: 
i) The dispersion of bulk fat globules into emulsion particles, 
ii) The enzymatic hydrolysis of fatty acid esters, and 
iii) The desorption and dispersion of insoluble lipid products into an absorbable form. 
The emulsification of ingested fat begins in the stomach, where long-chain TG may be stored for 2-4 
hours. During this time, peristaltic contractions facilitate the intra-gastric mixing of bulk phase fat 
globules with complex polysaccharides, membrane derived phospholipids, and peptic digests of dietary 
proteins which constitute potential emulsifiers (11 ). Enzymatic hydrolysis of TG also begins in the 
stomach. Most gastric lipolysis is catalyzed by lingual lipases which originate in the serous glands (von 
Ebner) beneath the circumvallate papillae of the tongue (13). Some authors have suggested that lin-
gual lipases digest as much as 30% of the total dietary TG (11 ). 
When gastric chyme is propelled through the pylorus into the duodenum, the shear forces exerted on 
the mixture promote the dispersion of dietary TG into small, stable emulsion particles (14) . Peristaltic · 
contractions facilitate the mixing of these particles with biliary lipids and bile salts, which aid fat emul-
sification (11 ). The hydrolysis of dietary TG is largely completed in the upper small intestine by a 
pancreatic lipase which cleaves the primary (sn-glycerol 1- and 3-) ester bonds of the TG molecules, 
generating from each a 2-monoglyceride and 2 free fatty acids (12) . Pancreatic lipase is present in in-
testinal chyme at concentrations some 100-1000 fold in excess of that needed for complete hydrolysis 
of the intestinal TG (11 ). This finding is consistent with the observation that TG absorption is extreme-
ly efficient in normal men. 
It is not known how the products of TG digestion desorb from the micelles of intestinal chyme and 
enter the absorptive enterocytes. There is general consensus that newly absorbed fatty acids and 
monoglycerides cross the microvillus membrane by passive diffusion and are re-esterified to TG within 
the smooth endoplasmic reticulum (SER) of the enterocyte. The predominant pathway within the SER 
is direct synthesis of TG from 2- monoglyceride and 2 molecules of activated fatty acid (15) . Morphologi-
cal studies have indicated that the re-esterified TG forms oil droplets in the SER and that these droplets 
are associated with phospholipids, cholesterol and cholesterol esters. These intracellular lipid ag-
gregates are referred to as pre-chylomicrons (16) . Several apolipoproteins (A-1, A-IV, and B) are added 
to the pre-chylomicron in the enterocyte, but it is not known whether these apolipoproteins are added 
Introduction 
at the same time, or where the association of lipid and protein occurs. Apo B is required for the syn-
thesis and secretion of TG-rich lipoproteins by the intestine (17), but the role of other apolipoproteins 
in these processes is less clear. Maturing chylomicrons move from the SER to the Golgi apparatus, 
where glycosylation of proteins takes place. During this time, the pre-chylomicrons become considerab-
ly enriched in phospholipid (16). 
During active lipid absorption, the Golgi cisternae become distended with pre-chylomicron droplets, 
and bud off from the Golgi apparatus to form vesicles. The vesicles containing pre- chylomicrons 
migrate towards the plasma membrane and release their contents into the intercellular space by ex-
ocytosis. The TG-rich lipoproteins which contain dietary lipids are now referred to as chylomicrons . . 
Structure of lymph chylomicrons: 
In intestinal lymph, chylomicron particles range in size from 80 to 500nm. Chylomicron size is believed 
to vary as a function of the rate of TG absorption (18) . The chemical composition of lymph chylomicrons 
may also vary, although TG invariably comprise the bulk of the particle weight. Zilversmit (19) reported 
that chylomicrons isolated from the intestinal lymph of a dog fed corn oil contained 95-96% TG, 3-4% 
phospholipid, 0.6% cholesterol, 0.2% cholesterol ester, and 0.6% protein. Comparable data were 
reported for human chylomicrons isolated from chyluric patients by Green et al (20). 
The gross architecture of the chylomicron particle is determined by its chemical composition. The 
particles are spherical, comprising a hydrophobic core of TG and cholesterol esters surrounded by a 
closely packed monolayer of cholesterol and phospholipid. The gaps between the polar heads of this 
monolayer are filled by apoproteins. Lymph chylomicrons have been shown to contain all major 
apoproteins (including A-1, A-II, A-IV, B, the C peptides, and E) . The apoprotein composition of 
chylomicrons isolated from chyluric patients (20) comprised 3.4% apo B, 10% apo A-IV, 4.4% apo E, 
15% apo A-I, and 47.3% apo A-II and C . . pa Animal studies have demonstrated that the small intestine 
is the site of synthesis of apo A-1 , A-IV and B (21 ), but the C peptides and apo E do not appear to be 
synthesized in the intestinal cells to any significant extent, and are probably transferred to the 
chylomicron surface after secretion (24) . Therefore the presence of these apolipoproteins in intestinal 
lymph samples indicates contamination by hepatic lymph and filtered plasma. 
Tissue specific heterogeneity of apo B has been shown in several species including man. These forms 
have been separated by polyacrylamide gel electrophoresis and are conventionally described in terms 
of the nomenclature proposed by Kane (22) . At least 2 forms, B48 and B100, are believed to occur in 
native lipoproteins. There is some evidence that these proteins are transcribed from the same gene. A 
post-transcriptional modification of the apo B mRNA in intestinal cells results in incomplete translation 
of the gene product (23) , resulting in a smaller protein (apo B48). To date, this modification has not 
been described in human liver cells. Accordingly in the human, apo B48 appears to be produced ex-
clusively in the intestine and may prove to be a useful marker of intestinal lipoproteins. 
lntravascular metabolism of chylomicrons: 
The intravascular metabolism of chylomicrons proceeds in 2 stages. Initially, the particles undergo 
sequential delipidation within the circulation. The TG component is hydrolyzed by an endothelial ·lipase 
(lipoprotein lipase) which is synthesized in most extrahepatic tissues, including adipose, skeletal 
muscle, heart muscle, lung, brain and adrenal gland (25) . The pivotal role of this enzyme in chylomicron-
TG clearance is clearly illustrated by the florid chylomicronemia which arises in patients with congeni-
tal lipoprotein lipase (LPL) deficiency (26), and by animal studies in which immunological blockade of 
LPL funct ion causes a dramatic rise in plasma TG concentrations (27) . The extrahepatic localization of 
the lipase suggests that most dietary TG is cleared from the circulation by peripheral (non-hepatic) tis-
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sues. This hypothesis is supported by animal studies in which the major fraction of radiolabled 
chylomicron-TG is recovered from adipose tissue and skeletal muscle after intravenous infusion (28,29). 
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If LPL hydrolysis is the rate-limiting step for chylomicron-TG clearance then it seems likely that 
postprandial serum TG concentrations will be determined largely by the aggregate LPL activity of the 
vascular endothelium. While the qualitative aspects of this relationship have been established, attempts 
to define a quantitative relationship between LPL activity and postprandial lipemia have been unsuc-
cessful. 
In contrast to the high correlation between postprandial lipemia and chylomicron-TG clearance 
reported by Nestel (30), several investigators have found weak correlations between postprandial serum 
TG concentrations and LPL activity measured during the fasted state in postheparin plasma (31) or in 
adipose tissue (32,33). It is not clear whether this finding reflects an inconsistency in the generally ac-
cepted model of chylomicron-TG removal, or an error in the extrapolation from in vitro determinations 
of LPL activity to the functional activity of LPL in the whole animal. Uncertainty regarding the relation-
ship between LPL activity and postprandial lipemia is compounded by 2 further considerations: 
a) Passive regulation of triglyceride clearance: 
The relationship between plasma TG flux and plasma TG concentration is usually analysed in terms 
of the classical theory of enzyme kinetics proposed by Michaelis and Menten. According toJhis theory, 
the curve described by plasma TG transport plotted against TG concentration assumes a hyperbolic 
shape. At low plasma TG concentrations, the rate of TG clearance is concentration dependent. Under 
these conditions (first order kinetics) , the fraction of the plasma TG pool removed per unit time is inde-
pendent of the pool size because the probability of any given productive particle-enzyme interaction 
ocurring is not diminished by the presence of other particles. The disappearance of a tracer or of a 
bolus of particles injected into this system conforms almost exactly to a monoexponential decay. 
As plasma TG concentrations increase further, however, the corresponding increase in the rate of TG 
clearance becomes smaller. At these rates of plasma TG clearance, TG removal no longer proceeds 
as a first order reaction. At very high concentrations of plasma TG, the clearance mechanism ap-
proaches saturation. At this point the rate of change of plasma TG clearance approaches zero order 
and further increases in the plasma TG concentration produce little or no change in the absolute rate 
of TG removal. 
In normolipidemic men, the TG clearance mechanism does not appear to become saturated during 
the postprandial phase (34). Brunzel! (35) and others (36) have reported that the TG clearance 
mechanism is saturable, but this condition occurs at plasma TG concentrations well above the normal 
level. While the TG clearance mechanism operates below its saturation threshold, variations in the ab-
solute rate of removal of TG can be achieved without any alteration in LPL activity or in the affinity of 
the enzyme for its substrate. This system will accommodate the waves of chylomicron-TG which enter 
the circulation during the postprandial phase, and will maintain the plasma TG concentrations within a 
relatively narrow range. For example, Grundy and Mok (37) reported that a 10 to 20 fold increase in.the 
rate of influx of TG into the circulation induced by intraduodenal infusion of TG led to a concomitant 
rise in the plasma TG pool size of less than 60% in normolipidemic men. 
Passive modulation of TG removal may also be effected by heterogeneity of the chylomicron struc-
ture which influences its interaction with LPL. Quarfordt and Goodman (38) reported that the TG of large 
chylomicrons have a shorter half life in the circulation than do the TG of small chylomicrons. Since 
chylomicron size appears to be proportional to dietary fat load (39), it is possible that the TG entering 
the circulation after a high fat meal are cleared more efficiently than those following a low fat meal. 
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For normal function against lipoprotein substrates, LPL requires an activator peptide, apo C-11 (40). 
Homozygous apo C-11 deficiency confers Type I hyperlipoproteinemia, the lipoprotein profile found in 
genetic LPL deficiency (41 ). This observation illustrates the absolute requirement for apo C-11 in normal 
chylomicron metabolism. Although it is generally accepted that the plasma concentration of apo C-11 
is not a determinant of chylomicron clearance rate (42), it is possible that the distribution of apo C-11 
between plasma lipoproteins may influence chylomicron clearance. Havel et al (43) reported that apo 
C-11 are transferred from HDL to chylomicrons during the postprandial phase. The transfer appeared to 
be proportional to the size of the accepter particles. The larger the chylomicrons, the more apo C-11 
they received. The apo C-11 content of chylomicrons may also be determined by the apo A-1 content of 
the nascent particles. Erkelens and Mocking (44) reported that apo C binding to artificial TG-rich par-
ticles (lntralipid) in vitro could be increased by prior incubation of the lntralipid with apo A-1. Further-
more, incubation with apo A-I in vitro increased both apo C-11 binding and lntralipid clearance in vivo. 
These studies suggest that chylomicron apolipoprotein composition may influence the metabolism of 
dietaryTG. 
The site of uptake of chylomicron-TG may also be passively modulated as a consequence of tissue-
specific heterogeneity of the affinity of LPL for TG substrate. Fielding et al (45) have reported tnat the 
LPL isolated from rat heart has a Km of 0.07mM, while the corresponding value for rat adipose tissue 
is 0. 70mM. These data indicate that normal plasma TG concentrations provide saturation of the heart 
lipase, but not of the adipose tissue enzyme. Nilsson-Ehle (46) has suggested that under fasting con-
ditions when plasma l=G levels are relatively low, TG uptake into adipose tissue will be comparatively 
small, while uptake into heart will proceed at a high rate. After the ingestion of a fatty meal, TG uptake 
into adipose tissue will increase with increasing plasma TG concentrations, while uptake into heart will 
remain constant as the lipase in this tissue is already saturated. This heterogeneity would facilitate the 
metabolic channeling of TG in accordance with the energy requirements of different tissues. 
b) Active regulation of TG clearance: 
In contrast to passive modulation, where the amount of substrate hydrolyzed varies without accom-
panying changes in LPL activity, active regulation of TG hydrolysis is accomplished by changes in en-
zyme activity. For example, adipose tissue LPL activity is increased postprandially in several strains of 
rats and in cattle (see 47 for review). This regulation is believed to be under hormonal control. Several 
hormones have been shown to influence LPL activity in adipose tissue. 
i) Insulin: Given the primacy of insulin in the regulation of glucose homeostasis, the concept that this 
hormone co-ordinates fuel substrate homeostasis during the postprandial state is teleologically attrac-
tive. In the metabolic scenario proposed by Nilsson-Ehle (46) the active regulation of LPL activity by in-
sulin augments the tissue specific uptake of plasma TG which occurs passively as a consequence LPL 
heterogeneity. Accordingly, under fasting conditions, low plasma insulin concentrations lead to low 
adipose tissue LPL activity, and hence a comparatively limited uptake of plasma TG into adipose tis-
sue. The postprandial rise in plasma insulin concentrations increases adipose tissue LPL activity and 
accelerates the rate of uptake of plasma TG into this tissue. The role of insulin in the acute regulation 
of adipose tissue LPL activity has been extensively studied in animals and in man (25,47,48). In the rat, 
abundant evidence in support of a physiological role for insulin in the regulation of adipose tissue LPL 
activity has been provided by in vivo and in vitro studies (25,47) . The evidence for a similar role in man 
is less clear, however. 
In vivo studies in man have indicated that the administration of glucose (49) or insulin and glucose 
(50) increases adipose tissue LPL activity, while prolonged insul in deficiency such as may occur in Type 
I diabetes diminishes the activity of this enzyme (51) . The physiological significance of this observation 
is dubious, as little (33) or no (52) increase in adipose tissue LPL activity occurs after mixed meals, 
despite substantial postprandial increments in postprandial lipemia. The discrepancy between the ef-
fects of glucose and mixed meals may be explained by the find ing that insulin-induced increases in 
4 
Introduction 5 
adipose tissue LPL activity are significantly blunted by the concomitant ingestion of fat (53) . Experi-
ments in which the source of dietary carbohydrates was varied to provide varying insulin responses 
raised further doubts regarding the role of insulin as a primary regulator of adipose tissue LPL activity. 
Paired feeding studies performed in hypertriglyceridemic patients indicated greater increases in 
adipose tissue LPL activity in response to fructose than to glucose, despite substantially higher plas-
ma insulin concentrations after glucose meals (54). On the basis of these studies Brunzel! et al (48) con-
cluded that insulin plays a permissive role, but not a primary role in the regulation of adipose tissue LPL 
activity. 
The effect of insulin on skeletal muscle LPL activity is uncertain. Some studies in the rat (55) have in-
dicated an inverse association between plasma insulin concentrations and LPL activity of heart and 
skeletal muscle, but no similar correlation has been found in normal or insulin-deficient man (56). More 
recent studies suggest that skeletal muscle LPL activity is maintained at low levels by normal car-
bohydrate intake (57) . Reduction of the carbohydrate content of the diet leads to increased LPL activity 
in skeletal muscle within 2 weeks. 
ii) Gastric inhibitory polypeptide (GIP): A possible role for GIP in the postprandial regulation of LPL 
activity and chylomicron TG clearance is suggested by in vitro studies (58) which indicate increased 
LPL activity in adipocytes exposed to this hormone. This hypothesis was supported by studies in dogs 
in which GIP administration in doses calculate to reproduce postprandial plasma GIP concentrations 
augmented the clearance of intravenously administered lymph chylomicrons (59) . Jorde, using the in-
travenous fat tolerance test, failed to reproduce these findings in humans (60). It is not known whether 
this discrepancy reflects species (dog versus human) or methodological (chylomicrons versus ln-
tralipid) differences. 
iii) Other gastrointestinal hormones: In vitro studies using adipose tissue from fasted rats indicate that 
the gastro- intestinal hormones gastrin and pancreozymin increase LPL activity at concentrations which 
simulate the fed state in vivo (61 ). The effect of gastrin appears to be glucose dependent, but that of 
pancreozymin is glucose-independent and cumulative with that of insulin. Eckel has suggested a pos-
sible role for these hormones, particularly pancreozymin, in regulating adipose tissue LPL in vivo (47) 
but the effects of these hormones on chylomicron clearance has not been studied. 
Other hormones including growth hormone, thyroid hormone, prolactin, the adrenergic hormones 
and the glucocorticoids have been shown to influence adipose tissue LPL activity (47) . The effects of 
these hormones are likely to result from chronic administration, and their role in the acute regulation of 
plasma TG concentrations is doubtful. Accordingly the effects of these hormones will not be considered 
further here. 
Fate of redundant surface material: 
The hydrolysis of TG in the chylomicron core causes a reduction in the volume of the particle, and 
consequently, the redundancy of polar surface material. Several studies have indicated that the red_un-
dant surface components are transferred to (or form) high density lipoproteins (see 62 for review). Ac-
cordingly, high density lipoproteins become enriched with phospholipids and Apo A-I during the hours 
following a fatty meal (63) . 
Chylomicron remnants: 
The end-products of the delipidation cascade are remnant particles which are largely depleted of TG 
(64) . Under normal conditions, chylomicron remnants are efficiently removed from the circulation by 
the liver (65) . There is overwhelming evidence from in vitro and in vivo studies to suggest that apo E is 
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essential for normal uptake of chylomicron remnants (66) . In subjects homozygous for apo E2, a form 
of apo E which exhibits grossly impaired binding to hepatic membranes in vitro (67), the half life of 
chylomicrons is increased about 4 fold (68). 
The nature of the apo E binding site on hepatic cells has not been clearly elucidated. One possibility 
is that chylomicron remnants are cleared by the apo B,E (low density iipoprotein) receptor described 
by Goldstein and Brown. The observation that chylomicron remnant clearance is normal in homozygous 
Watanabe heritable hyperlipidemic rabbits (69), a mutant in which apo B,E receptors are not function-
al, led some authors to propose a specific "remnant" receptor which binds apo E but not apo B (see 70 
for review) . In vitro studies suggested that this putative receptor had a very high affinity for apo E-con-
taining lipoproteins (71). Recent efforts to clone this receptor have been unsuccessful, however. Fur-
thermore, Windler have et al (72) have reported that apo B,E receptors account for at least 50% of 
chylomicron-remnant uptake in the perfused rat liver. 
The clearance of chylomicron remnants is believed to occur almost entirely within the d1 .006 
lipoprotein fraction. Studies in which intestinal lipoproteins have been labeled with retinyl palmitate (73) 
or apo 848 (74) have indicated that the chylomicron-remnants do not form lipoproteins of highe·r den-
sity. This is in contrast with the TG-rich lipoproteins of hepatic origin, some of which give rise to apo 
8100 containing lipoproteins in the LDL range. The mechanism responsible for the distinct metabolic 
fates of hepatic- and intestine-derived TG- rich lipoproteins is not known. 
Introduction 
Aims and scope of this study: 
The primary aim of the work described in this thesis was to determine whether postprandial increases 
in plasma TG concentrations are actively damped by increases in TG clearance. Although the regula-
tion of the clearance mechanism(s) has been extensively investigated, the regulation of chylomicron-
TG clearance per se has received little study. Therefore, while it is clear that several hormones can 
potentially increase TG clearance (as described above), the composite effects of these factors under 
physiological conditions are not known. 
One reason for the paucity of in vivo investigations into the postprandial regulation of TG metabolism 
is the lack of a definitive method whereby the disappearance of diet-derived TG can be measured. Nas-
cent lymph chylomicrons are not readily available from normal donors, therefore various indirect 
methods to assess chy1omicron clearance have been devised. Little in vivo validation of these methods 
has been attempted, and each has been criticised on theoretical grounds. Furthermore, no compara-
tive studies of the different methods are available. Accordingly, the three most commonly used methods 
were compared and validated in this study. Further discussion of this work is presented in Chapter 2. 
Intuitively, it seems likely that active regulation of chylomicron clearance would be triggered in 
response to feeding. Since few studies have examined the effects of different nutrients (fats, proteins 
and carbohydrates) on postprandial serum TG concentrations, if js not clear whether such a response 
occurs, or how it is mediated. In the present study, the effects of these factors have been evaluated. 
Chapter 3 describes the effects of varying the amount and type of dietary fat on postprandial lipemia. 
In Chapter 4, the effects of dietary protein are considered. The possible roles of different carbohydrates 
are evaluated in Chapter 5. 
Physiological perturbation of plasma TG metabolism can be induced by chronic endurance exercise 
training. The effects of chronic exercise training on the plasma TG response to fat feeding, and on 
chylomicron clearance have not been extensively studied. In the present study, postprandial lipemia 
and chylomicron clearance have been evaluated in endurance trained athletes. These results are 
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CHAPTER1: GENERALMETHODOLOGY 
1) Procedures for assessing chylomicron-triglyceride clearance: 
General considerations: 
All procedures used to assess chylomicron-TG clearance were approved by the Ethics and Research 
Committee of the University of Cape Town. The studies were performed on an outpatient basis on sub-
jects following their self-selected diets. Subjects were asked to refrain from alcohol use for at least 72 
hours, from exercise for 24 hours, and from food and beverages (excluding water) for 12 hours before 
each test. 
i) Oral fat tolerance testing: 
a) Procedure: 
8 
Oral fat tolerance testing was performed according to the procedure described by Patsch et al (75) . -_ 
On arrival at the laboratory the subjects were seated, and blood samples were drawn from an antecubi-
tal vein into plain tubes. The appropriate test meal was then administered. In all cases, the meals were 
presented in liquid form, and were consumed within 1 O minutes. The subjects were then allowed to 
leave the laboratory in order to continue with their customary daily activities. No further food or beverage 
(excepting water) was consumed, and no exercise was permitted during the tests. Subsequent blood 
samples were drawn at 2,4,6 and 8 hours after the meal, except where otherwise indicated. In order to 
determine whether significant quantities of TG appeared in the plasma within 2 hours after the meal, 
blood samples were drawn from 22 subjects 1 hour after the ingestion of 100ml cream (40g fat). In 
these samples, the average TG increment above the fasting value was 10%. 
b) Analysis of data: 
A curve describing changes in serum TG concentration with respect to time was constructed using 
linear interpolation. The curve was normalized to zero by subtracting the fasting serum TG concentra-
tion from each Y-coordinate. Postprandial lipemia (mg.dL-
1.hr) was calculated by numerical integration 
of the area under the curve. 
c) Reproducibility: 
The reproducibility of the oral fat tolerance test was estimated using test meals comprising 100, 200 
and 350ml fresh cream (40% fat w/v) . In 8 subjects (5 men and 3 women) tested on 2 occasions with 
100ml cream, mean inter-test variation was 16%. In 8 men tested on 2 occasions with 200ml cream, 
mean inter-test variation was 18%. In 20 men tested on 2 occasions with 350ml cream, mean inter-test 
variance was 20%. In each case the test procedures were separated by an interval of 3 weeks. These 
data compare favorably with the inter-test variation of 20% reported by Angervall (5) in subjects given 
200ml heavy cream. Raw data are given in Table 1. 
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Table 1. Reproducibility data of oral fat tolerance tests using three fat loads. 
350ml Cream 200ml Cream 100ml Cream 
(140g fat) (80g fat) (40g fat) 
No. Test1 Test2 
t 
(d) Test1 Test2 (d) Test1 Test2 (d) 
: (mg.dl"1.8hr) (mg.dL.
1.shr) (mg.dl.1.Shr) 
1) 1072 1007 6 305 350 14 46 60 26 
2) 340 270 23 546 686 23 315 . 371 16 
3) 232 173 29 507 405 22 143 116 21 
4) 303 356 16 819 871 6 193 223 14 
5) 199 383 63 403 536 28 262 248 5 
6) 479 550 14 580 521 11 176 159 10 
7) 406 294 32 445 310 36 250 270 8 
8) 519 576 10 538 560 4 116 90 25 
9) 288 224 . 25 
10) 380 308 21 
-
11) 619 545 13 
12) 1293 1387 7 
13) 629 466 30 
14) 503 558 10 
15) 662 577 14 
16) 239 200 18 
17) 584 569 3 
18) 604 .483 22 
19) 832 695 18 
20) 779 623 22 
-
X 548 512 20 518 530 18 188 192 16 
Abbreviations: No. = Subject number, (d) = percentage difference between test 1 and te~t 2. 
Note: No. denotes a different subject for each test dose. 
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ii) Intravenous fat tolerance testing: 
a) Procedure: 
Intravenous fat tolerance testing was performed according to the procedure described by Rossner 
(76) . On arrival at the laboratory, subjects were seated and an indwelling cannula was placed in an an-
tecubital vein and kept patent by slow saline infusion. A fasting blood sample was drawn and a bolus 
of 20% lntralipid (0.5mlJkg) was then administered within 15 seconds via the cannula. To remove 
residual lntralipid, the cannula was flushed with 25ml of saline. Three ml of blood were then drawn 
and discarded. Further blood samples were drawn at 5, 7.5, 10, 12.5, 15, 20, 25, and 30 minutes after 
lntralipid infusion unless otherwise indicated. 
b) Analysis of data: 
The rate of disappearance of lntralipid is expressed as the first order rate constant (k2) as described 
by Hallberg (35). The data were assumed to follow a monoexponential decay, and k2 was calcalated 
from the log-linear plot of plasma lntralipid concentration versus time. An estimate of the fit of the data 
to a monoexponential decay curve (r) is given for each set of data. The k2 was expressed as percent-
age disappearance of lntralipid-TG per minute (%/min). 
c) Reproducibility: 
Intravenous fat tolerance was determined on 2 occasions in 14 normolipidemic young men. Mean 
inter-test variation was 12.1 % (see Table 2) . 
Table 2. Reproducibility data for Intravenous fat tolerance tests. 
Test1 Test2 (d) 
k2 (min) k2 (min) 
1) 6.6 7.6 13.6 
2) 4.7 4.6 2.2 
3) - 6.0 6.6 9.5 
4) 6.3 . 5.7 10.0 
5) 4.1 3.3 22.2 
6) 2.8 3.2 13.3 
7) 2.8 3.3 16.4 
8) 4.6 5.1 10.3 
9) 5.1 5.8 12.8 
10) 4.3 4.7 9.4 
11) 4.3 3.7 15.0 
12) 6.3 5.1 21 .1 
13) 7.7 8.3 7.5 
14) 4.7 4.5 4.3 
-
X 5.0 5.1 12.1 
Key: (d) == percentage difference between Test 1 and Test 2 
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iii) Duodenal perfusion studies: 
a) Procedure: 
Duodenal perfusion studies were performed in the gastro-intestinal clinic at Groote Schuur Hospital, 
using the method described by Grundy and Mok (37). On arrival at the clinic, a naso-duodenal tube 
was positioned in the third portion of the duodenum under fluoroscopic guidance. Subjects were then 
confined to bed, and a fat emulsion was infused at a rate of 175mg fat/kg body weight/hour for 1 O hours. 
Blood samples were taken just before, and at 5,6, 7,8,9, and 1 O hours after the start of the infusion. The 
blood was collected into tubes containing EDTA (1 .2mg/ml) and aprotinin (500 units/ml). Plasma was 
collected by low speed centrifugation. From each hourly sample drawn during the steady state period 
1 ml plasma was taken and pooled. Mean steady-state chylomicron-TG concentration was determined 
from the pooled sample. 
b) Analysis of data: 
Chylomicron-TG half life was calculated using the formula 1 
t1/2 =0.693/k 
where k = input rate of chylomicron-TG/plasma chylomicron-TG pool size. 
Chylomicron pool size was calculated from the plasma volume and the plasma concentration of 
chylomicron-TG. Plasma volume was calculated from the formula 1 
Plasma volume (ml) = 927 + 31.47 x body weight(kg) 
2) Laboratory methods: 
a) Lipid analyses: 
i) Triglyceride concentration: 
The TG concentrations of serum and plasma, and of chylomicron fractions isolated by ultracentrifuga-
tion, were determined using a commercial enzyme kit (kit 240052, Boehringer Mannheim GmbH, Man-
nheim, West Germany) . The TG assays were standardized against curves determined from serial 
dilutions (range 46 to 368mg/dl} of a lyophilized control serum (Precilip, Boehringer Mannheim). The 
assays were invariably linear within this range (typical regression values were r = 0.999, y-intercept = 
-3.2} and intra- assay variance estimated from duplicate aliquots of 30 samples was less than 5%. 
Samples to be analysed within 24 hours of collection were stored at 4 degrees C. Samples to be stored 
for longer periods were kept frozen at -20 degrees C. All samples from a single experiment were analysed 
in a single batch. 
l. See reference 37 
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ii) lntralipid-TG concentration: 
Most previous studies (76,77) of intravenous fat tolerance have used photometric measurements to 
determine lntralipid-TG concentration. These procedures are performed on whole serum or plasma 
samples and therefore measure not only exogenous lipids (lntral ipid) but also all endogenous 
lipoproteins which produce light diffusion in serum. The significance of the contribution of endogenous 
lipoproteins to the optical properties of plasma is not clear. While Rossner et al (76) reported an excel-
lent correlation between plasma lntralipid-TG concentration and light scattering index determined by 
nephelometry, a comparative study by Lambert et al (78) indicated that lntralipid-TG concentrations 
estimated by spectrophotometric methods were poorly correlated with those determined by 
ultracentrifugation or by decantation in a polyvinylpyrrolidone gradient. 
To determine whether spectrophotometry could be used to provide a reliable index of serum lntralipid-
TG concentration, the relationship between serum optical density and lntralipid-TG concentration was 
investigated as follows: 
a) lntralipid was added to a fasting serum sample to give a final concentration of 500mg lntralipid-
TG/dl plasma. A standard curve was calculated from 1 O serial dilutions of 10% each. Serum optical 
density and lntralipid-TG concentration were linearly related over this range (r=0.99) , and the regres-
sion line included the origin (see Figure 1) 
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Figure 1. Linear regression analysis comparing serum optical density with serum lntralipid-triglyceride 
concentration. 
b) Twenty samples of plasma drawn at varying times during intravenous fat tolerance tests were diluted 
1 :20 with normal saline. The optical density of these samples was then determined (in duplicate) by 
spectrophotometry at 650nm within 12 hours of sample collection. Intra-assay variation of the 
spectrophotometric procedure was less than 1 %. In duplicate aliquots of these samples, lntralipid par-
ticles were isolated by preparative ultracentrifugation (as described below). The TG concentration of 
the supernatant was measured enzymatically. Correlation (r) between the TG concentration of the su-
pernatant (lntralipid TG) and the optical density of serum was 0.98 (see Figure 2). 
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Figure 2. Linear regression analysis comparing serum optical density with serum lntralipid-triglyceride 
concentration determined by ultracentrifugation. 
These findings indicate that the spectrophotometric method provides an indication of plasma ln-
tralipid-TG concentration which is both accurate and precise. Therefore in all.further experiments, serum 
optical density was considered to reflect lntralipid-TG concentration. 
iii) Cholesterol concentration: 
The cholesterol concentrations in serum or plasma, or in high- density lipoprotein (HDL) fractions iso-
lated by precipitation were determined enzymatically (Boehringer Mannheim kit no. 237574) . The assay 
was standardized against lyophilized control sera (Precilip and Precilip E.L.) containing 166mg and 
397mg cholesterol per decilitre respectively. For assay of HDL cholesterol, the 166mg/dl standard was 
diluted fourfold. Samples were stored at 4 degrees C and analysed within 24 hours of sample collec-
tion. Intra-assay variation estimated from 30 samples was less than 5%. 
iv) Fatty acid analyses: 
Plasma- or VLDL lipids were separated by thin layer chromatography using the solvent system 
petroleum ether:diethyl ether (peroxide free):acetic acid (85:15:2 v/v/v) (14). Lipids were located on the 
plates by spraying with 2,5-cli(5-tert-butyl- 2-benzoxazolyl)-thiophene) and viewing under ultraviolet 
light. Spots containing TG were scraped off and trans-methylated by heating with 5% H2S04-methanol 
for 2 hours at 70 degree C. Fatty acid methyl esters were then extracted with n-hexane and separated 
in a Varian 4600 gas liquid chromatograph on 2m glass columns of 2mm internal diameter, packed with 
10% SP 2330 Chromosorb W, 100-200 mesh. Flow rates were: hydrogen 20mLJmin, air 200mLJmin, 
nitrogen 20mLJmin. Temperature programming was linear at 3 degrees C/min (initial temperature 150 
degrees C, final temperature 220 degrees C, injector temperature 260 degrees C, detector temperature 
270 degrees C) . Fatty acid peaks were detected by flame ionization. Fatty acids were identified by com-
parison with known standards. Quantitation was achieved by the area-ratio method using a Varian 402 
integrator. 
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b) Lipoprotein analyses: 
i) Isolation of chylomicrons: 
Two ml of serum or plasma were overlayered with sodium chloride solution (d = 1.006gm/ml) and 
subjected to preparative ultracentrifugation in a Beckman SW-41 rotor at 8.5x1 o9 rad2/sec. During this 
procedure, lipoproteins of Sf> 1000 move to within 0.5cm of the top of the tube (79). Two ml of the su-
pernatant were carefully aspirated using a modified Pasteur pipette (80). The TG content of the aspirate 
was considered to represent chylomicron TG. Intra-assay variance for chylomicron TG determination 
(estimated from 20 samples) was less than 10%. Chylomicron TG concentration was determined in 
plasma samples taken from 3 fasted subjects. In two of the subjects chylomicrons were not recovered 
in fasting plasma, while in the third subject, less than 3% of the plasma TG was recovered in the 
chylomicron fraction. 
ii) Separation of high-density lipoproteins: 
High density lipoproteins (HDL) were separated from lipoproteins of lower density using the methods 
described by Gidez et al (81), and by Warnick et al {82). These methods are based on selective, 
polyanionic precipitation of the apo B- and apo E-containing lipoproteins (LDL and VLDL) , leaving HDL 
in the infranatant. The method of Gidez et al (81) includes a second precipitation which facilitates the 
separation of HDL into subclasses resembling the HDL2 and HDL3 achieved by preparative 
ultracentrifugation. Intra- assay variance estimated from duplicate analysis of 30 samples was less than 
5% for the HDL estimation and less than 8% for HDL2 estimation. 
c) Other Analyses: 
i) Glucose: Plasma glucose concentrations were measured in duplicate on a Beckman glucose 
analyser (Model ERA 2001). Intra-assay variation was less than 5%. 
ii) Insulin: Plasma insulin concentrations were measured in duplicate by radioimmunoassay using a 
kit obtained from Pharmacia Diagnostics. Intra-assay variation was less than 4% 
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CHAPTER 2: A COMPARISON OF THREE METHODS FOR ASSESSING 
CHYLOMICRON TRIGLYCERIDE CLEARANCE 
INTRODUCTION: 
Several methods have been used to assess the rate of clearance of diet-derived, or "exogenous" TG. 
In some studies, direct measurements of chylomicron-TG clearance have been obtained by measur-
ing the rate of disappearance of a bolus of intravenously injected chylomicrons (30,83). This method 
involves the homologous administration of endogenously labeled chylomicrons isolated from thoracic 
duct lymph, and its use has been limited by ethical and practical considerations. Therefore in most 
studies, chylomicron-TG clearance has been assessed by indirect methods such as oral (5, 75) or in-
travenous (76,84) fat tolerance tests, which do not provide quantitative estimates of chylomicron-TG 
clearance. 
The oral fat tolerance test is based on the assumption that the magnitude of triglyceridemia which fol-
lows the ingestion of a fatty meal (postprandial lipemia) is inversely related to the rate of chylomicron-
TG clearance. Indirect support for this hypothesis is provided by the observation that, in the absence 
of gastro-intestinal pathology, TG absorption is extremely efficient (85) . If it is assumed that the bulk of 
TG absorption occurs within 7-8 hours postprandial, the integrated area under the curve of plasma TG 
concentration plotted against time (postprandial lipemia) should reflect chylomicron TG half-life. Ac-
cordingly, in several recent studies (31 ,32, 75). postprandial lipemia was considered to be analogous 
to chylomicron-TG half life. More direct evidence that postprandial lipemia is determined by 
chylomicron-TG half life is limited to a single study by Nestel (30) , who reported a strong inverse cor-
relation between postprandial lipemia and the rate of _clearance of intravenously administe.red 
chylomicrons in a mixed group of normo- and hypertriglyceridemic men. Since. the rate of TG absorp-
tion is not controlled during the oral fat tolerance test, chylomicron-TG clearance cannot be quantita-
tively determined by this method. Rossner (76) has suggested that vagaries in the rate of fat absorption 
severely limit the utility of the oral fat tolerance test, but no relationship between any parameter of fat 
absorption and postprandial lipemia has been reported in normal men. 
The intravenous fat tolerance test was devised in order to eliminate TG absorption as a confounding 
factor in the estimation of chylomicron-TG clearance. For this test, an artificial fat emulsion is used to 
model the intravenous decay kinetics of chylomicron-TG. Early studies {86) indicated that many artifi-
cial fat emulsions are taken up by the reticuloendothelial system and are therefore unsuitable for use 
as tracers of chylomicron metabolism. In 1963, Schuberth {87) reported that a fat emulsion comprising 
soya oil and egg lecithin in a glycerol base (lntralipid, Vitrium AB Stockholm, Sweden) showed excel-
lent clinical tolerance. Moreover, this emulsion appears to resemble chylomicrons in several respects: 
In vitro studies have indicated that lntralipid particles associate with apo CII {88) and act as a substrate 
for LPL in postheparin plasma {89) . Hallberg {35) reported that lntralipid- and chylomicron-TG had 
similar decay kinetics after intravenous injection in man. 
On the basis of these studies, the intravenous fat tolerance test has been widely used, both in cross-
sectional studies such as comparisons of normal and hypertriglyceridemic men (76), and in longitudinal 
investigations into the effects of experimental perturbations involving diet (84) or exercise (90). In most 
studies of normolipidemic men, however, the mean half life of intravenously injected lntralipid-TG is 
about 15 minutes {76), whereas the half life of chylomicron-TG determined under similar conditions is 
about 6 minutes {30,83) . Furthermore, the sensitivity of the intravenous fat tolerance test to intra- in-
dividual changes in plasma TG clearance is not known, as the responsiveness of the test to small, but 
unequivocal changes in the rate of intravascular lipolysis has not been tested. 
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More recently, Grundy and Mok (37) have developed a method whereby chylomicron-TG clearance 
can be calculated from steady- state plasma chytomicron-TG concentrations. These conditions are 
achieved by perfusing the duodenum with TG at a constant rate. This method is based on two assump-
tions: Firstly, the rate at which chylomicron-TG enter the blood is considered to be equal to the rate of 
influx of perfusate-TG into the duodenum. Secondly, it is assumed that the chylomicron fraction iso-
lated using ultracentrifugation contains all of the chylomicron-TG, but none of the "endogenous" TG of 
plasma. While these assumptions remain unproven, chylomicron-TG clearance estimated using this 
method in normolipidemic men (37) is similar to the rate of disappearance of intravenously injected 
chylomicron-TG (30) . 
Although collation of results from different studies suggests that these indirect methods yield general-
ly consistent results in the cross-sectional comparison of normolipidemicand hyperlipidemic individuals 
(5,30,37), a comparative study of the different methods has not been undertaken. In the absence of 
such data, and given the different assumptions on which each of these tests are based, the degree to 
which observations concerning the clearance of chylomicron-TG are affected by the measuring tech-
nique employed is unknown. The present study was undertaken in order to compare the oral, in-
travenous, and intraduodenal methods of estimating chylomicron-TG clearance, and to determine the 
sensitivity of the intravenous fat tolerance test to experimentally-induced changes in plasma TG 
clearance. 
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METHODS: 
1) Subjects: 
Three methods for assessing chylomicron TG clearance were compared in twelve normolipidemic, 
male medical students who were apparently in good health (Group A, see Table 3 for clinical data) . 
These men followed self-selected diets, and all had been weight stable for the 6 months preceding the 
study. One subject was mildly obese (24% body fat) as determined from skinfold measurements (91 ). 
None of the subjects smoked or used any medication known to affect lipoprotein metabolism. Three 
subjects were competitive marathon runners. 
The effects of heparin on intravenous fat tolerance were examined in ten normolipidemic young men 
(mean age = 29.± 4 yr) and 2 women (aged 30) who did not smoke and who did not regularly use any 
medication known to affect lipoprotein metabolism (Group B). These subjects were apparently healthy, 
and all performed regular, moderate exercise (1 to 3 hours per week) . 
2) Procedures: 
. i) Oral fat tolerance test: 
Oral fat tolerance testing was performed in subjects in Group A as described in Chapter 1 using meals 
comprising 100ml cream (40g fat), 1 teaspoon (3g) chocolate flavouring, and 300ml water. Serum was 
collected by low speed centrifugation (3000g for 15 minutes), stored at 4 degrees C, and analysed for 
TG concentration within 24 hours of sample collection. 
ii) Intravenous fat tolerance test: 
Intravenous fat tolerance testing was performed as described in Chapter 1. To compare the in-
travenous fat tolerance test with other tests of chytomicron clearance, a single fat tolerance test was 
performed in the 12 men in Group A. To determine the effects of heparin on lntralipid clearance, a 
baseline intravenous fat tolerance test was performed in 12 subjects in Group B. Ninety minutes after 
the completion of the baseline test, an intravenous infusion of heparin was started. Six subjects received 
12.5 units of heparin per minute, while the other 6 received 25 units per minute. Fifteen minutes after 
commencing the heparin infusion, a second intravenous fat tolerance test was performed. The heparin 
infusion was maintained for the duration of the test. In each case, the same batch of lntralipid was used 
for both tests. 
To control for systematic errors which might be incurred by performing the tests at different times 
during the morning, intravenous fat tolerance was examined in 3 subjects at 8.00 am and again at 11.30 
am on the same day. During these procedures, no heparin was given. 
iii) Effects of heparin on endogenous serum TG concentrations: 
Heparin (12.5 or 25 units per minute for 45 minutes) was infused into fasting subjects via a cannula 
placed in an ante-cubital vein. Five subjects received ttie higher dose and 2 subjects the lower dose in-
fusion. Blood samples were drawn into plain tubes before, and at 5 minute intervals during the infusion. 
Serum TG concentrations were measured enzymatically using a method which discriminates between 
free and esterified serum glycerol (Test kit 877557, Boehringer Mannheim). 
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iv) Duodenal perfusion: 
Duodenal perfusion was performed in subjects in Group A as described in Chapter 1 using a fat emul-
sion comprising 1 OOg olive oil and 7g gum acacia per litre of water. A previous study has indicated that 
fat given orally in this form is efficiently absorbed in normal men {92) . In 7 subjects, chylomicrons were 
isolated from each sample drawn during the perfusion (see Chapter 1 ). The remaining d.006 lipoproteins 
were then isolated from these samples by ultracentrifugation at 41000 rpm for 22 hours. Chylomicron 
and VLDL lipids were extracted {93), and separated by thin layer chromatography. The fatty acid com-
position of the TG spots was determined by gas chromatography (see Chapter 1). 
3) Analysis of data: 
Postprandial lipemia, k2 of lntralipid decay, and the t1/2 of chyfomicron-TG were calculated as 
described in Chapter 1. 
In another study performed in this laboratory (see Chapter 5 and reference 94), the magnitude of 
postprandial lipemia appeared to be normally distributed in normolipidemic subjects. Therefore the cor-
relations between the parameters measured in the present study were determined using Pearson's 
method {95). To exclude the possibility of spurious correlations arising as a consequence of non-nor-
mal distribution of the data, correlations were also determined using a non-parametric method 
(Spearman's ranked correlation procedure) . The mean values of the lntralipid decay constants obtained 
before and after heparin infusion were compared using Wilcoxon's signed rank test for paired data. 
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RESULTS: 
The procedures were well tolerated and none of the subjects developed nausea or diarrhoea during, 
or after any of the tests. The results are reported as the mean.±.standard deviation. Detailed test results 
are shown in Tables 3 and 4. 
i) Oral fat tolerance: 
Fat ingestion increased the serum TG concentration in all subjects. On average, serum TG concentra-
tions were maximally elevated at 2 hours (mean maximum increase = 55.± 42mg/dl). and had returned 
to fasting values within 8 hours after the meal (see Figure 3) . 
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Figure 3. Mean serum triglyceride concentrations of 12 normolipidemic men after the ingestion of 
100ml dairy cream. 
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ii) Intravenous fat tolerance: 
lntralipid clearance was adequately fitted by a single exponential in all subjects in group A (mean 

















0 5 10 15 20 
Time (min) 
25 30 35 
Figure 4. Mean serum optical density of 12 normolipidemic men after intravenous lntralipid administra-
tion (0.5ml lntralipid/kg body weight) . 
iii) Duodenal perfusion: 
In all subjects, plasma TG concentrations were increased by duodenal TG perfusion (mean increase 
in plasma TG = 69.±37mg/dl, see Figure 5) . Sixty percent of the increment in plasma TG concentra-
tion was recovered in the chylomicron fraction, and a further 30% was recovered in the VLDL fraction 
(d < 1.006, Sf< 1000}. The mean TG concentration of the samples drawn during the 5 hour steady state 
period was considered to represent the steady state TG concentration. The average variation of plas-
ma TG concentrations around the steady state value was less than 11 %. Variation of the chylomicron 
TG concentration around the steady state concentration averaged 17%. Oleic acid (C18: 1) constituted 
81 % of the TG fatty acids in the perfusate, and 41.±5% of the TG fatty acids extracted from VLDL frac-
tion obtained from 7 fasted subjects. The mean oleic acid content of the chylomicron-TG remained con-
stant throughout the perfusion (75.±3% at 5, and at 1 O hours) . 
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Figure 5. Mean serum triglyceride concentrations of 12 normolipidemic men during duodenal fat per-
fusion (175mg triglyceride/kg body weight/hour) . 
iv) Correlations: 
Pearson correlation coefficients between postprandial lipemia, lntralipid half life, chylomicron-TG half 
life and fasting serum TG concentration are shown in Table 3. Correlation coefficients determined using 
Spearman's ranking method were lower than the Pearson correlation, but were significantly different 
from O (P < 0.05.) for all parameters tested. 
Table 3. Pearson correlation coefficients (r) between postprandial lipemia (PPL), t1/2 for 
lntralipid clearance (lt1/2), t1/2 for chylomicron triglyceride clearance (Ct1/2), and fast-
ing triglyceride concentration (FTG). 
PPL lt1/2 Ct1/2 
FTG .79 .80 .77 
Ct1/2 .84 .82 
lt1/2 .84 
P< .0025 for n = 12 and r=0.75 
Chapter 2. Comparison of three methods for measuring chylomicron triglyceride clearance , 22 
Table 4. Clinical data and triglyceride clearance measurements of subjects in Group A. 
AGE BWT %BF TC FTG PPL lt1/2 Ct1 /2 
1 21 90 18 207 89 269 16.1 4.8 
2 30 93 24 190 106 584 27.7 10.3 
3 21 70 12 175 68 99 16.1 2.2 
4 20 74 11 185 97 214 17.3 8.7 
5 21 67 12 160 91 384 13.9 6.2 
6 20 64 15 148 46 102 10.3 3.8 
7 20 68 12 148 45 221 12.8 3.2 
8 19 68 15 170 29 33 7.5 2.4 
9 21 65 10 160 41 46 10.5 2.5 
10 21 55 11 168 72 105 11.4 2.5 
11 27 66 14 172 53 218 11 .8 3.6 
12 26 70 12 155 60 121 9.6 3.3 
-
X 22 71 - 14 170 66 200 13.7 4.5 
s.d. 3 11 4 18 25 158 5.2 2.6 
Abbreviations: BWT = body weight (kg) , %BF= percent body fat, TC = total cholesterol concentration 
(mg/di), FTG =fasting triglyceride concentration (average of three test days, mg/di) , PPL= postpran-
dial lipemia (mg.dL-1.8hr) , lt1 /2 = lntralipid half life (minutes). Ct1 /2 = chylomicron-triglyceride half life 
v) Effects of heparin on serum TG concentrations and intravenous fat tolerance: 
Heparin infusion decreased serum TG concentrations in all subjects (see Figure 6). The mean maxi-
mum decrease from the fasting value was 16.±JOmg/dL (24.±.15%, range 12 to 54%) during the 25 
unit/minute infusion. In the 2 subjects who received the 12 unit/minute infusion, serum TG concentra-
tions were decreased by 22 and 24%. In 4 -subjects, serum TG concentrations decreased progressive-
ly throughout the infusion. The remaining subjects reached steady state serum TG concentrations within 
30 minutes after commencing the infusion. 
-Heparin infusion increased the k2 of lntralipid disappearance in all subjects in Group B (see Figure 7) . 
Mean k2 was 5.3.±.1.8%/minute before and 9.8.±.3.4%/minute after the 25unit/minute heparin infusion 
(P < 0.025) . In the subjects who received the 12.5 unit/minute infusion, mean k2 was 7.3.±.2.3%/minute 
before, and 15.0.±.9.3%/minute after heparin administration (P < 0.05). In all studies, the data were ade-
quately fitted by a slngle exponential (r = 0.96) . The large mean value for k2 after the 12.5 unit/minute 
heparin infusion was due to disproportionately high responses in 2 subjects (k2 = 25 and 27%/minute). 
Since no clear dose response relationship was apparent in our study, data from the 2 groups have 
been combined for the purposes of the discussion. The k2 values of the control studies were 6.6, 4.3, 
and 6. 7 %/min at 8.00 am. The corresponding values were 6.5, 4.4, and 6.9 %/min at 11.30 am. 
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Figure 7. Plasma lntralipid concentrations of 6 normolipidemic men during infusion with normal saline 
(e) and heparin (25 units/minute) (II. 
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DISCUSSION: 
The results of this study indicate that oral and intravenous fat tolerance tests, and the duodenal per-
fusion method of Grundy and Mok (37), provide qualitatively similar assessments of chylomicron-TG 
clearance in normolipidemic men. The mean values for postprandial lipemia, lntralipid half life, and the 
half life of chylomicron clearance of the men in this study were similar to those found in normolipidemic 
men in previous studies (37,76,96), and good correlations were obtained between these methods for 
estimates of chylomicron-TG half life ranging from 2.2 to 10.3 minutes (estimated using the duodenal 
perfusion method). The results of the non-parametric correlation procedure indicate that these correla-
tions were not due to outliers or to other artifacts of data distribution. 
It is possible that the correlations obtained between these methods were the fortuitous conse-
quence(s) of factors unrelated to TG clearance. The tests are based on different theoretical assump-
tions, however, and it is difficult to formulate an alternative hypothesis to explain the correlations 
observed. For example, the oral and intraduodenal perfusion methods both rely on the efficient absorp-
tion of TG from the gastrointestinal tract. Therefore the correlation observed between these 2 methods 
may reflect absorptive processes, rather than clearance. This possibility must be considered unlikely 
for the following reasons: 
1) Both the oral fat tolerance test and the duodenal perfusion method show good correlation with the 
intravenous fat tolerance test, which is clearly unrelated to TG absorption. 
2) The inverse relationship between chylomicron-TG clearance and fasting serum TG concentration 
is believed to reflect a common clearance pathway for hepatic and intestine derived TG-rich lipoproteins 
(36). Therefore the strong correlations between postprandial lipemia, chylomicron-TG half life and fast-
ing serum TG concentration observed in the present study suggest that the rise in· serum TG concentra-
tions measured after oral and after intraduodenal fat administration was limited by events within the 
intravascular compartment, rather than at the site of TG absorption. 
3) Other studies performed in this laboratory (see Chapter 3 and reference 94) have indicated that 
postprandial lipemia (measured as area under the curve) increases in direct proportion to meal fat con-
tent after oral fat loads ranging from 40 to 120g. If postprandial lipemia was limited by the rate of fat ab-
sorption, then increasing fat loads would produce disproportionately small increases_in the magnitude 
of postprandial lipemia. 
4) A strong inverse correlation between the magnitude of postprandial lipemia and the rate of clearance 
of intravenously injected chylomicrons has been reported previously (30). This finding suggests that 
postprandial lipemia is limited by TG clearance, rather than by absorption. 
Given these considerations, it seems likely that the correlations between the three methods used in 
this study reflect a common dependence on the rate of chylomicron-TG clearance. 
Postprandial lipemia, chylomicron TG clearance and endogenous TG pool size: 
The results of the present study support a previous observation (30) that the magnitude of postpran-
dial lipemia is determined largely by the rate of chylomicron-TG clearance. The rate of chylomicron-TG 
removal is determined in part by the efficiency of the TG removal system(s) and possibly by the plas-
ma endogenous TG pool size. Therefore the relationship between chylomicron-TG half life, lntralipid 
half life and postprandial lipemia observed in the present study may reflect a common dependence on 
fasting plasma TG pool size, as each of these methods showed strong correlation with fasting plasma 
TG concehtration. Two longitudinal studies have provided support for this concept: 
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· Using the duodenal-perfusion method, Grundy and Mok (37) found impaired chylomicron-TG 
clearance in subjects with endogenous hypertriglyceridemia. Dietary (caloric) restriction reduced en-
dogenous TG concentrations and concomitantly increased chylomicron TG clearance in 7 out of 8 sub-
jects. Similar changes were noted in most subjects following Clofibrate treatment. 
Brunzel! et al (36) found that fasting chylomicronemia (which was considered to reflect impaired 
chylomicron clearance) could be induced in hypertriglyceridemic subjects by increasing dietary car-
bohydrate intake, and hence endogenous TG production. The appearance of fasting chylomicronemia 
Was not related to increased chylomicron formation, as dietary fat intake was held constant in these 
studies. Post-heparin plasma LPL activity was not diminished by carbohydrate ingestion in these men, 
therefore it seems unlikely that the diminution of chylomicron-TG clearance was secondary to impaired 
TG removal capacity. · 
If chylomicron TG clearance ls dependent on the endogenous TG pool size, and if the endogenous 
plasma TG pool size is determined primarily by VLDL production, as suggested by Tobey et al (97), 
then the rate of chylomicron-TG clearance would not necessarily reflect the capacity of the TG removal 
system(s). This hypothesis would explain the poor correlation found in several studies (31,32,33) be-
tween LPL activity (which presumably reflects TG clearing capacity) and postprandial lipemia. A further 
implication of thjs argument is that _both fasting and postprandial plasma TG concentrations are deter-
mined by the rate of VLDL production. 
Some authors have suggested that measurements of chylomicron-TG clearance are not simply a 
reflection of endogenous TG pool size, however, and several studies have reported that the fractional 
clearance of chylomicron-TG and the fasting plasma TG concentration can be independently perturbed. 
Hallberg.(98) reported that the fractional removal rate of lntralipid is not reduced by increasing rates of 
lntralipid infusion and hence lntralipid concentration. In healthy women, Rossner (99) found that the 
fractional clearance rate of lntralipid is not affected by estrogen administration, despite a significant in-
crease in plasma TG concentration. Nestel (84) reported that acute exposure to.diets comprising 80% 
carbohydrates increased fasting plasma TG concentrations by 100% but did not affect the fractional 
clearance rate of lntralipid. In another study performed in this laboratory (see Chapter 7 and reference 
100) chylomicron-TG clearance measured by oral and intravenous tolerance tests and by duodenal 
perfusion was faster in endurance-trained athletes than in sedentary men matched for fasting TG con-
centration. These findings suggest that the relationships between postprandial lipemia, lntralipid and 
chylomicron half life, and fasting TG concentrations reflect a common dependence on the activity of 
the TG clearing system(s) . 
Since the rate of plasma TG removal is limited by the activity of LPL, measurements of the activity of 
t_his enzyme may provide an estimate of TG removal capacity which is independent of possible con-
founding factors such as TG pool size. Accordingly, the observation (101) that post-heparin plasma 
LPL activity is negatively correlated with fasting serum TG concentration, and with endogenous TG turn-
over in normolipidemic men and women supports the hypothesis that fasting TG concentrations and 
the parameters of TG clearance estimated in the present study are related by a common dependence 
on the activity of the TG removal system(s). This hypothesis is further supported by the study of Pagano 
Mirani-Oostdijk (102), in which diurnal changes in serum TG concentrations in normolipidemic men on 
high carbohydrate diets appeared to be related to changes in adipose tissue LPL activity. 
Other population based studies (103) have failed to show significant correlation between LPL activity 
and serum TG concentrations, however, while studies in rats suggest that physiological variations in 
adipose tissue LPL activity are poorly correlated with changes in the kinetic behaviour of VLDL (104) . 
Furthermore, factors such as the enzyme source (tissue or postheparin plasma), method of extraction 
from tissue, and dose of heparin administered may determine the apparent LPL activity, and it is not 
clear which of these methods best reflects the in vivo TG clearing capacity (105). 
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Validation of the duodenal perfusion method: 
An estimate of chylomicron-TG. half life obtained using the duodenal perfusion method (37), has been 
widely quoted as a standard for normolipidemic men. The mean chylomicron-TG half life reported by 
those workers (37) is in good agreement with that reported by Nestel et al (30) for the clearance of in-
travenously administered chylomicrons, but no further validation of the duodenal perfusion method has 
been described. In the present study, the mean chylomicron-TG half life of 12 normolipidemic men es-
ti_mated using the duodenal perfusion method was identical to that reported by Grundy and Mok (37) . 
In addition, the present data provide support for the assumptions underlying the duodenal perfusion 
method. 
Firstly, Grundy and Mok (37) assumed that the absorption of intraduodenally administered TG was 
complete, on the basis of the extensive fat balance studies performed by Annegers, Boutwell and Ivy 
(85) . The present data provide further support for this contention, as described in detail above. 
The second assumption of the test, ie. that chylomicrons can be completely separated from en-
dogenous lipoproteins by ultracentrifugation, is more contentious. Chylomicrons entering the intravas-
cular compartment are subject to. progressive delipidation by LPL. This process generates a 
heterogeneous population of partly catabolized intestine-derived lipoproteins, which ~hows con-
siderable overlap with the density range of hepatic VLDL (39,74). The separation of chylomicrons from 
endogenous TG-rich lipoproteins is therefore based on an operational definition, rather than on a true 
physiological distinction. If the presence of endogenous VLDL in the chylomicron fraction leads to 
spuriously elevated estimations of chylomicron-TG concentration, then the calculated rate of 
chylomicron-TG clearance will underestimate the true value. Grundy and Mok (37) elected to use the 
Sf> 1000 lipoproteins to represent chylomicrons on the basis of electrophoretic studies which indicated 
good separation of exogenous and endogenous lipoproteins. In their study, less than 5% of the TG in 
fasting plasma samples was recovered in this fraction. This convention has recently been adopted by 
other authors (106) . In the present study, the fatty acid composition of the TG in the Sf> 1000 
Ii po proteins was analysed in order to determine the relative proportions of endogenous and exogenous 
TG in this fraction. 
This analysis indicated that 93% of the TG in the "chylomicron" fraction was derived from the perfusate. 
These data suggest that the chylomicron fraction isolated in this study was relatively free of contamina-
tion with endogenous lipoproteins, although some of the perfusate-derived TG recovered in this frac-
tion may have already recycled through the liver. While the endogenous TG contribution to this fraction 
was minimal under fasted conditions, it is possible that hepatic VLDL with a flotation rate of Sf> 1000 
are secreted under conditions of acute fat feeding. 
Conversely, the ultracentrifugation procedure used in this study may yield spuriously low estimates 
of chylomicron-TG concentration, and consequently half life. In most studies, the lipoprotein fraction 
Sf> 400 isolated using the isopycnic ultracentrifugation method described by Havel et al (107) has been 
considered to represent chylomicrons. Redgrave and Carlson (108) reported that most of the postpran-
dial increase in plasma TG concentrations occurred in the Sf> 400 fraction isolated by density gradient 
ultracentrifugation. Lewis et al (39) reported a direct relationship between dietary fat load and the frac-
tion of plasma TG appearing in the Sf> 400 fraction for meals containing from 1 to 1 OOg fat. After each 
meal, however, an appreciable proportion of the plasma TG increase appeared in the Sf100-400 frac-
tion. These data suggest that the Sf> 400 fraction may not contain the entire chylomicron fraction. In 
the present study, the fraction of the perfusion-induced increment in plasma total TG concentration 
recovered in the chylomicron (Sf> 1000) fraction averaged 60%, while a further 30% was recovered in 
the d < 1.006 lipoproteins which floated at Sf< 1000. The magnitude of the perfusion-induced increment 
in plasma TG concentration was strongly correlated with chylomicron-TG content (r = 0.86). Given the 
strength of this correlation, and since the distribution of the perfusate-derived TG is probably continuous 
in the d.006, SfdO lipoprotein fraction, it seems unlikely that the apparent chylomicron-TG half life would 
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be qualitatively altered by the inclusion of almost any sub-population of this fraction in the estimation 
of total chylomicron-TG concentrat ion. Furthermore, even if the perfusion-induced increment in plas-
ma TG concentration was considered to be constituted entirely by chylomicrons, an assumption which 
ignores the TG content of chylomicron-remnants and probably of some hepatic VLDL, mean 
chylomicron half life would be 7.9 minutes. This value, which represents the most extreme possible 
overestimate of chylomicron- TG half life obtainable with the duodenal perfusion method, is still in good 
agreement with the value obtained by direct methods (30) . Therefore it appears reasonable to conclude 
that the duodenal perfusion method yields values for chylomicron-TG half life which are consistent with 
those achieved by other methods, and which do not overestimate, nor significantly underestimate the 
true value. 
Validation of the intravenous fat tolerance test 
The results of the heparin infusion studies indicate that the intravenous fat tolerance test is sensitive 
to experimentally induced increases in plasma TG clearance. Heparin infusions that decreased the en-
dogenous plasma TG concentration by as little as 12% caused significant increases in the rate of ln-
tralipid clearance. In the 3 control studies in which no heparin was given, the rate of lntralipid 
disappearance remained constant during the study period. Therefore, while the resolving power of the 
intravenous fat tolerance test was not precisely quantitated in this study, the data suggest that the test 
will readily detect small changes in the rate of plasma TG clearance. 
The magnitude of the heparin-induced changes in plasma TG clearance was assessed from measure-
ments of endogenous TG concentrations. This estimate is based on the assumption that the decrease 
in endogenous TG concentration measured during heparin infusion is due almost entirely to a heparin-
induced increase in plasma TG clearance. Since the plasma TG clearing action of heparin is secondary 
to the liberation of endothelial lipases into the circulation (109), it might be argued that in vitro measure-
ments of plasma lipolytic activity would provide a more direct estimate of changes in intravascular 
lipolytic activity, and thus of plasma TG clearance. The doses of heparin used in the present study are 
much lower than those employed for maximal release of endothelial lipases into the circulation (36), 
however, and the proportion of intravascular lipolytic activity remaining on the endothelium (and con-
sequently inaccessible to in vitro assay) under these conditions is not known. Accordingly, changes in 
intravascular lipolytic activity could not be reliably determined from measurements of plasma lipolytic 
activity. 
Previous studies have suggested that exogenous and endogenous TG- rich lipoproteins may com-
pete for a common clearance pathway (36). Consequently, the rate of lntralipid clearance is determined 
in part by the size of the endogenous plasma TG pool. Since heparin infusion decreases the endogenous 
TG concentration, the increased rate of lntralipid clearance measured in the present study may be part-
ly attributable to a reduction in the number of endogenous TG-rich lipoprotein particles. To evaluate 
the fraction of the heparin-induced increase in lntralipid clearance which can be attributed to reduced 
TG-pool size, we calculated the regression of k2 on fasting serum TG concentration in the 12 nor-
molipidemic young men who comprised group A. These data were chosen because of the high cor-
relation (r = 0.80) between these 2 parameters in this sample. The regression coefficient (b) was -0.603 
in this sample. From these data, it can be calculated that a 16mg/dl decrease in endogenous plasma 
TG concentration (the average decrease in the present study) would result in a 1 %/minute increase in 
the rate of lntralipid clearance. Since the heparin-induced increase in k2 averaged 6.1 %/minute it can 
be concluded that less than 17% of this increase is attributable to changes in endogenous TG con-
centration. 
The observation that lntralipid clearance is sensitive to small changes in the rate of plasma TG 
clearance provides further support for the validity of this emulsion as a tracer of the lipolytic phase of 
chylomicron metabolism. In addition, these findings suggest that the intravenous fat tolerance test can 
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be used to determine whether experimental perturbations of serum TG concentrations are secondary 
to increased intravascular lipolytic activity. 
In summary, the results of the present study indicate good agreement between 3 indirect methods for 
assessing chylomicron-TG clearance. The correlations between these methods reflect a common de-
pendence on chylomicron-TG clearance, rather than on unrelated factors such as TG absorption. The 
rate of chylomicron clearance is related to fast ing TG pool size. It is not clear, however, whether, or to 
what extent the relationship between clearance and pool size reflects a common dependence upon the 
TG removal system(s). 
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INTRODUCTION: 
29 
Dietary TG is•almost completely absorbed in healthy men (85) , therefore postprandial serum TG con-
c·entrations are likely to be determined, at least in part, by the quantity of TG consumed in a meal. 
Postprandial plasma TG concentrations may also vary according to the type of fat consumed. Despite 
widespread interest in the effects of dietary fats on plasma lipids, the relationship between the TG con-
tent of a meal and the magnitude of postprandial lipemia induced by the meal has not been systemati-
cally studied. 
Postprandial plasma TG concentrations may be acutely regulated by fat-induced increases in plasma 
TG clearance. Since postprandial lipemia is largely determined by the rate of plasma TG clearance (see 
Chapter 2} , it is likely that putative regulation of postprandial TG concentrations would be effected within 
the circulation. Fat ingestion may augment plasma TG clearance by 2 mechanisms: 
Firstly, it is possible that fat ingestion may stimulate the release of factors which increase the activity 
of the TG clearing system(s). Eckel et al (58} , and Bourdeaux et al (61} have reported that the gastro-
intestinal polypeptides GIP and pancreozymin increase the synthesis of LPL by adipocytes in vitro. The 
physiological significance of these factors in the regulation of chylomicron clearance is uncertain, 
however. While Wasada et al (59} reported that exogenous GIP administration increases chylomicron 
clearance in dogs, GIP does not appear to increase lntralipid clearance in humans (60} . 
Secondly, since the rate of clearance of chylomicron-TG appears to be proportional to chylomicron 
size (38} , and since the proportion of large chylomicrons secreted after a meal appears to be related 
to meal fat content (39}, it is possible that the postprandial serum TG excursion following large fat meals 
may be passively ameliorated as a consequence of the structure of the resulting chylomicrons. 
In a study of a single individual, Moreton (110} reported that the postprandial increment in the amount 
of Tyndall light scattered by serum (which was considered to be an index of alimentary lipemia) was 
-directly proportional to the quantity of fat ingested. This finding suggests that acute fat feeding does 
not stimulate the rate of clearance of plasma TG, an hypothesis consistent with the subsequent obser-
vation that fat ingestion does not stimulate the activity of adipose tissue LPL (49}, which is believed to 
represent the principal removal pathway for chylomicron-TG clearance (46} . 
Conversely, Kingsbury et al (111) reported that fat loads in excess of 70g did not produce propor-
tionate increases in postprandial serum TG concentrations. If it is assumed that fat absorption was com-
plete in these subjects then disproportionately low increases in postprandial lipemia with increasing fat 
loads suggest increased fractional clearance of plasma TG at higher fat loads. 
Few investigators have examined the effects of TG-fatty acid saturation on postprandial lipemia. In a 
study of the acute effects of a variety of oils on plasma lipids Kingsbury et al (111) noted differences in 
the plasma glyceride responses to different oils but the importance of TG-fatty acid composition was 
not examined. Engelberg (112} reported that TG-fatty acid saturation did not affect postprandial lipemia. 
This observation was supported by Kashyap et al, who reported no systematic effect of P/S ratio on 
postprandial lipemia induced by mixed meals in 6 subjects (113}. Conversely Harris et al (114} reported 
that the postprandial rise in plasma TG levels was markedly lower after salmon oil than after a saturated· 
fat meal. Since salmon oil did not appear to be malabsorbed, these authors suggested that dietary sal-
mon oil increased the rate of clearance of chylomicrons. 
Chapter 3. Meal fat content and postprandial lipemia 30 
The present experiments were undertaken to invest igate the relationship between meal fat content 
and postprandial lipemia. My interest in this relationship arose from the observation that in many recent 
studies (31 ,75} postprandial lipemia has been measured after the consumption of very large fat loads 
(350ml heavy cream) . Clearly the consumption of this quantity of TG in a single meal does not reflect 
the dietary custom of Western man, and the relevance of such studies to conventional dietary practice 
depends upon a linear relationship between fat load and postprandial lipemia. If the magnitude of 
postprandial lipemia does not vary linearly with the TG dose administered, then conclusions made from 
studies using a standardized fat load can only be appl ied to that particular fat load. In order to exclude 
possible variation due to the type of fat consumed, or to non-fat components in the meal, the effects of 
three different quantities of dairy cream on postprandial serum TG concentrations were examined in 
normolipidemic young men. In a second experiment, the serum TG responses to meals containing 
primarily saturated, monounsaturated or polyunsaturated fats were compared. 
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METHODS: 
1) Subjects: 
24 male medical students aged between 20 and 25 volunteered for this study. All were moderately ac-
tive (1 to 2 hours of exercise per week) nonsmokers and none used any medication known to affect 
lipoprotein metabolism. Glucose intolerance was excluded by oral glucose tolerance test (115). All had 
fasting serum TG concentrations below 200mg/dl, and serum cholesterol concentrations below 
250mg/dl, on two occasions prior to the study. With one exception, all were non-obese (% body fat as 
determined from skin fold measurements (91). The remaining subject was moderately obese (26% body 
fat) . 
2) Oral fat tolerance tests: 
i) Effects of increasing meal fat content: 
The effects of increasing quantities of dairy cream were examined in 12 subjects. Standard pretest 
meals consisting of four (machine-sliced) slices of white bread, 40g peanut butter, 20g jam, 250ml 
sweetened orange juice and 500ml whole milk, provided by the investigators were eaten at 6.00 pm 
on the evening prior to testing. No food or drink (excepting water) was consumed thereafter, until the 
commencement of testing at 8.00 the following morning. 
Oral fat tolerance testing was performed as described in Chapter 1, using meals comprising 100ml 
(meal 1), 200ml (meal 2), and 300ml (meal 3) cream. The sequence in which the test meals were ad-
ministered was randomized. The cream used in this experiment was purchased in a single batch and 
stored at -20 degrees C until use. One hundred ml of cream contained 40g fat. Analysis of the TG frac- · 
tion of the cream by gas chromatography indicated a fatty acid composition of 11%C14:0, 30% C16:0, 
14% C18:0 and 27% C18:1. 
ii) Effects of TG-fatty acid saturation: 
The serum TG responses to saturated, monounsaturated and polyunsaturated fats were evaluated in 
12 men. Saturated fat (meal 4) was given in the form of 100ml light cream (20g fat) and 20g fractionated, 
hydrogenated palm oil (Morpalm, Marine Oil Refiners, Cape Town). Palmitate (C16:0) and stearate 
(C18:0) comprised 43% and 36% respectively of the TG-fatty acids in this meal. Olive oil (81%C18:1, 
meal 5) and sunflower oil (72% C18:2, meal 6) were used as sources of monounsaturated and polyun-
saturated fats respectively. These oils were emulsified in 60ml water with glycerol monostearate (2g) 
and cholesterol (O.Sg). Each meal contained 40g fat. 
To determine whether the serum TG responses to sunflower oil could be increased by additional fat 
loading, the subjects were given an additional meal (meal 7) comprising 80g sunflower oil, 4g glycerol 
monostearate and 1 g cholesterol. 
3) Analyses: 
Serum cholester.ol and TG concentrations were determined in a single batch as described in Chapter 
1. The fatty acid composition of the meals was determined by gas chromatography as described in 
Chapter 1. 
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4) Statistics: 
Alimentary lipemia was calculated from the area under the curve described by serum TG concentra-
tions plotted against time (see Chapter 1). Fasting and postprandial serum TG concentrations and 
postprandial lipemia were compared using the paired t-test. The P values were corrected according to 
Bonferroni's procedure. 
Chapter 3. Meal fat content and postprandial lipemia 33 
RESULTS: 
i) Effects of increasing meal fat content: 
The test procedures were well tolerated by all subjects, although most felt slight, transient nausea after 
consuming 300ml cream. One subject had diarrhoea and minimal postprandial lipemia after ingesting 
300mL cream. This condition persisted when the test was repeated, and these data were therefore ex-
cluded from subsequent analyses. Mean fasting serum TG and cholesterol concentrations, postpran-
dial lipemia and maximum postprandial serum TG concentrations are shown in Table 5. Mean fasting 
serum TG concentration was similar on each test day (P > 0.25), but mean postprandial lipemia and the 
mean maximum postprandial serum TG concentration increased in direct proportion with the dose of 
fat administered. 
Table 5. Fasting serum cholesterol (FTC) and triglyceride (FTG) concentrations, 
postprandial lipemia (PPL) and maximum postprandial serum triglyceride con-
centrations (MTG) in 12 normolipidemic men fed 3 doses of dairy cream. 
Meal 1 Meal 2 Meal 3 
(40g fat) (80g fat) (1209 fat) 
FTC (mg/dL) 190.±.28 190.±.34 184.±.23 
FTG (mg/dL) 92.±.37 96.±.61 87.±.23 
PPL (mg/dL-1.Shr) 251.±.129 503.±.233 712.±.281 
MTG (mg/dL) 59.±.27 115.±.47 143.±.38 
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Figure 8. Serum triglyceride responses to 40g a,, 80g (e), and 120g (+) fat ingestion in 12 nor-
molipidemic men. 
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After each meal, serum TG concentrations increased rapidly, and maximum (or near maximum) levels 
were usually achieved within 2 hours. Mean serum TG had returned to baseline (fasting) concentration 
within 8 hours after meals 1 and 2 but not after meal 3. Extrapolation of the individual curves to baseline 
at 10 hours increased the mean postprandial lipemia after meal 3 from 712 to 742mg.dl.
1.8hr. 
ii) Effects of TG-fatty acid saturation: 
.The test procedures were well tolerated by all subjects and none reported nausea or diarrhoea after 
any of the tests. Mean fasting TG concentrations were similar before each meal. Mean postprandial 
lipemia increased with increasing TG-fatty acid saturation (see Table 6) . The mean postprandial lipemia 
was significantly lower after polyunsaturated than after saturated fat. 
Table 6. Serum triglyceride responses of . 12 normolipidemic men to meals containing 40g 
saturated (SAT), monounsaturated (MUF), and polyunsaturated (PUF) fat. 
SAT MUF PUF 
FTG 86..±..41 85..±..30 83..±..32 
PPL 161..±..86 130..±..98 84..±..34* 
PPI 53..±..28 56..±..34 41..±..23 
Abbreviations and units:FTG=fasting triglyceride concentration (mg/dl), PPL=postprandial lipemia 
(mg/dL-1. 7hr), PPI = peak postprandial triglyceride increment above fasting triglyceride concentration 
· *P < 0.01 compared with SAT (paired t-test) 
On average, peak postprandial serum TG concentrations occurred between 2.5 and 3.5 hours after 
saturated and polyunsaturated fat meals, and at 3.5 hours after the monounsaturated fat meal. Mean 
serum TG concentrations measured 7 hours after saturated and monounsaturated fats were similar to 
the fasting values. Seven hours after the 40g polyunsaturated fat meal, mean serum TG concentrations 
was 30% lower than the fasting value (P < 0.025) . 
. 
In 2 subjects, serum TG concentrations were still increasing 7 hours after the meal containing 80g 
sunflower oil. These data were therefore excluded from further analysis. In the remaining 10 subjects, 
serum TG concentrations were maximally increased 4 hours after the meal. Mean postprandial lipemia 
was 169.±.122mg.dL"
1.7hr in these men. The corresponding value for these 10 subjects after 40g 
sunflower oil was 83..±..39mg.dL· 1. 7hr. 
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DISCUSSION: 
The results of this study indicate that the changes in serum TG concentration which follow the con-
sumption of a fatty meal vary linearly with the fat content of the meal. This relationship was observed 
over a range of fat intakes typically consumed by men following Western diets. The range of fat loads 
within which a direct dose-response occurs is somewhat greater than was previously believed. 
Kingsbury et al (111) suggested that test meals containing more than 60-70g fat did not produce propor-
tionate increases in plasma lipid concentrations, although no data were provided to support this 
hypothesis. It is possible that this discrepancy is due (at least in part) to differences in the palatability 
of the test meal. In the present study, the fat load was presented in a palatable form, and although most 
subjects reported some discomfort after consuming meal 3 (containing approximately 120g fat). this 
was invariably transient. The appearance of dietary fat in blood (as judged from changes in serum TG 
concentration) was not delayed at any of the dosages tested, indicating that the onset of fat absorp-
tion occurred at a similar time after each test meal. In preliminary studies, however, changes in serum 
TG concentrations following the ingestion of an equal quantity of fat presented in a less palatable form 
(olive oil mixed with skimmed milk) were delayed for several hours (J Cohen, unpublished observa-
tions) . 
Although a direct dose-response relationship was observed for both alimentary lipemia (measured as 
area under the curve) and the maximum postprandial serum TG concentrations after 40g and 80g fat, 
these responses deviated somewhat from this pattern after consumption of 120g fat. This discrepancy 
was small for the measurement of total alimentary lipemia (a 2.84 fold increase over meal 1 (40g fat) 
compared with an expected 3 fold increase) and probably indicates that fat absorption was not com-
pleted during the 8 hour measuring period, as serum TG concentrations had not returned -to baseline 
after eight hours in some individuals. The lipemia calculated to 8 hours would therefore underestimate 
total postprandial lipemia. If the curves of those individuals whose serum TG had not yet returned to 
fasting values at 8 hours were extrapolated to baseline at 1 O hours, mean postprandial lipemia was in-
creased to 742mg.dL-1.8hr, reflecting excellent agreement with the expected value (753mg.dL-1.8hr): 
The discrepancy between observed and expected values was somewhat greater for the maximum 
postprandial serum TG concentration (a 2.42 fold increase over meal 1 instead of an expected 3 fold 
increase). The most likely explanation for this discrepancy is that the maximum rate of fat absorption 
was reached at a dose intermediate between meals 2 and 3. Beyond this point, additional fat loading 
would not increase the rate of influx of TG into the circulation, and thus the peak postprandial serum 
TG concentration would not be further elevated . 
• It might be argued that malabsorption of fat occurred at the highest fat load used in this study, result-
ing in a lower peak serum TG concentration than would otherwise be expected. This possibility must 
be considered unlikely, as previous studies suggest that fat absorption is very efficient, even after large 
fat meals (85). Patsch et al (75). reported that very small amounts of fat were recovered in the faeces 
during the 72 hours following meals containing 350mL heavy cream. 
Acute fat feeding and the regulation of postprandial lipemia: 
If fat ingestion stimulates the fractional rate of plasma TG clearance then incremental fat loads would 
be expected to produce progressively smaller increases in postprandial lipemia. The finding that in-
cremental fat loads produce directly proportional increases in postprandial lipemia therefore suggests 
that the hormonal factors elicited by acute fat feeding do not expedite the removal of TG from the cir-
culation. This observation is consistent with the finding that adipose tissue LPL activity is not stimulated 
by acute fat feeding (49). Therefore, while the ingestion of fat increases the plasma concentration of 
hormones which appear to increase adipose tissue activity in vitro, it appears reasonable to conclude 
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that the postprandial serum TG excursion is not actively damped by fat-induced increases in TG clear-
ing capacity. 
The linear relationship between fat load and plasma TG concentration also indicates that passive aug-
mentation of the fractional rate of chylomicron clearance due to dose related changes in chylomicron 
size and structure does not play an important role in the regulation of postprandial plasma TG con-
centrations. Therefore the postulate that large fat meals lead to the formation of large chy1omicrons {39) 
which appear to be more efficiently cleared from the circulation in the rat {38) is probably of little sig-
nificance in man. 
Postprandial saturation of the TG-removal mechanism{s): 
While it is now generally accepted that chylomicron and VLDL-TG are removed from the circulation 
by a common pathway, there is still some controversy concerning the saturability of this mechanism, 
and the importance of "saturation kinetics" in various forms of hypertriglyceridemia {34). Grundy and 
Mok {37) found that the infusion of a fat emulsion into the duodenum at a rate of 200mg/kg/hour, which 
presumably caused an equivalent increase in the rate of TG influx into the circulation, resulted in rela-
tively small changes in plasma TG concentrations. With continued infusion, a new steady state plasma 
TG concentration was achieved. These data indicate that the removal pathway of plasma TG is not 
saturated under these conditions. In the present study, saturation of the TG removal mechanism would 
have been indicated by higher aggregate postprandial serum TG concentrations after meal 3 than would 
be predicted in terms of a simple linear dose-response. Clearly, this did not occur. 
Therefore, although the relative rates of TG influx into, and efflux from the circulation were not inde-
pendently quantitated in this study, the linear relationship observed between dietary fat load and serum 
TG concentration supports the hypothesis that, under physiological conditions, the serum TG removal 
pathway is not saturated in normolipidemic man. 
Although several lines of evidence suggest that chylomicron-TG clearance is not saturated under 
physiological conditions in normal men, it cannot be assumed that the relation between chylomicron-
TG flux and concentration is entirely first order. Recent studies using non-linear kinetic analysis {160) 
of TG disappearance data in the dog indicate that better predictions of intravenous TG clearance can 
be obtained from models which include an area of mixed order, in which both zero order and first order 
processes operate simultaneously. This concept is attractive because it allows for the possibility of com-
petition for clearance sites between chylomicrons and VLDL as proposed by Brunzel! et al {36). In these 
studies {160) plasma TG concentrations during the infusions were elevated some 60-fold above the nor-
mal fasting concentration. Since feeding seldom increases the fasting plasma TG concentration more 
than 2 or 3- fold in man, the physiological relevance of these results is debatable. 
Effects of TG-fatty acid saturation on postprandial lipemia: 
The results of the present study suggest that postprandial lipemia is significantly affected by the de-
gree of saturation of fat in the test meal. Meals comprising largely saturated fat caused significantly 
greater increments in postprandial serum TG concentrations than did meals comprising polyun-
saturated fat. These findings may reflect malabsorption of polyunsaturated fat. This possibility seems 
unlikely, as several studies have indicated that corn oil (in which linoleic acid is the primary TG fatty 
acid) is almost completely absorbed in normal volunteers, even in doses several times greater than 
those employed in the present study (116). To evaluate the possibility of malabsorption in the present 
study, the subjects were given an additional meal containing 80g sunflower oil. If the low postprandial 
serum TG concentrations measured after 40g sunflower oil were due to malabsorption, then it seems 
likely that increasing doses of sunflower oil would yield little or no further increase in postprandial plas-
ma TG concentrations. Accordingly, the observation that doubling the dose of sunflower oil lead to a 
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proportionate increase in postprandial lipemia suggests that the low postprandial lipemia observed after 
40g sunflower oil is not due to diminished absorption. 
An alternative explanation for the diminished postprandial lipemia after sunflower oil ingestion is that 
chylomicron TG clearance is faster after the ingestion of polyunsaturated fat than after saturated fat. 
This process may be mediated in several ways: 
1) Sunflower oil may increase the activity of the TG clearance system(s) . Support for this concept is 
sparse, however, and a previous study has indicated that the ingestion of 30g corn oil does not increase 
adipose tissue LPL activity (49) . Furthermore, the direct dose response relationship observed in the 
present study between sunflower oil and plasma TG conce_ntrations suggests that stimulation of the 
clearance mechanism does not increase with increasing doses of polyunsaturated TG. 
2) The ingestion of polyunsaturated fats may generate chylomicrons which are cleared more readily 
from the circulation, resulting in relatively low postprandial lipemia. On the basis of in vivo fat tolerance 
studies using salmon oil (114), and the in vitro lipolytic studies of Engelberg (112) in which TG-rich 
lipoproteins from subjects fed fish oil appeared to provide better substrate for LPL than did TG-rich 
lipoproteins from subjects on uncontrolled diets, Goodnight et al (117) have suggested that 
chylomicrons containing omega-3 fatty acids may be more readily cleared from the circulation than are _ 
those containing saturated fats. 
Studies in animals suggest that the low postprandial lipemia after polyunsaturated fat feeding observed 
in the present study and in the study of Harris and Connor (114) is not related to putative alterations in 
chylomicron structure induced by polyunsaturated fat ingestion, however. In rats and dogs, the 
clearance of intravenously infused homologous lymph chylomicron- TG was similar, regardless of 
whether the donor animals had been fed cream or corn oil (118) . 
Furthermore, in apparent contradiction of his in vitro findings, and in contrast to the findings of the 
present study, Engelberg (112) cited unpublished observations which suggested that postprandial 
lipemia in man was not influenced by fat saturation. Therefore in the absence of in vivo evidence that 
the effects of TG saturation on postprandial serum TG concentrations reflect structural differences in 
the chylomicrons, the validity of this hypothesis remains open to question. 
3) A third possibil ity is that hepatic VLDL release is diminished by polyunsaturated fat ingestion. 
Diminished VLDL release would decrease plasma TG concentration directly, by decreasing the plasma 
concentration of endogenous TG, and possibly also indirectly, by decreasing the plasma pool of en-
dogenous plasma TG-rich lipoproteins which may compete with chylomicrons for a common clearance 
pathway. This hypothesis would explain the present finding that serum TG concentrations were reduced 
below the fasting value 7 hours after sunflower oil ingestion, when hepatic VLDL would be expected to 
provide the major source of plasma TG. 
In summary, the present experiments illustrate the significant effects both of the amount and the type 
of ingested fat on postprandial serum TG concentrations. For a given type of TG, postprandial lipemia 
rises in direct proportion to the quantity of TG in the meal. These data suggest that fat ingestion does 
not lead to an increase in the fractional rate of fat clearance. If similar amounts of fat are ingested, 
postprandial lipemia will be lower after polyunsaturated than after saturated fats. This difference does 
not appear to be due to differences in TG absorption. From the experimental evidence available to date, 
however, it is not possible to determine which of the mechanisms described above is responsible for 
the effects of TG-fatty acid saturation on postprandial lipemia. 
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Previous studies have indicated that postprandial lipemia may be significantly influenced by the fat 
(see Chapter 3) and carbohydrate (see Chapter 5) content of a test meal. The influence of dietary protein 
on the degree of postprandial lipemia evoked by a standard fat meal has received little study, however. 
Sullivan (119) reported that serum TG concentrations measured 3 hours after the ingestion of a fatty 
meal may be increased by the addition of protein to the test meal. The results of this study are difficult 
to interpret, as only 4 of the 6 subjects in the study exhibited increased postprandial lipemia after protein 
ingestion. Accordingly, the effects of protein ingestion on postprandial lipemia have remained unclear. 
The present study was undertaken to examine the effects of acute protein ingestion on postprandial 
lipemia and on intravenous fat tolerance. 
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METHODS: 
1) Subjects: 
Fifteen normotriglyceridemic medical students (12 men and 3 women, mean age 20.±.2 years, mean 
body weight 67 .±.12 kg) were recruited for this study. None of the subjects smoked, and none used 
any medication known to affect lipoprotein metabolism. 
2) Procedures: 
i) Oral fat tolerance tests: 
Each subject performed 2 oral fat tolerance tests in random order. On one occasion, the test meal 
consisted of 100ml cream, 3g chocolate flavouring, and 300ml water (meal 1). For the second test, 
25g of a commercial protein powder (Casilan) containing 93% sodium caseinate was added to the meal 
(meal 2). Blood samples were drawn into plain tubes just before, and at 2, 3, 4, 6 and 7 hours after the 
meal. The serum TG concentration of each sample was determined enzymatically (see Chapter 1 ). 
· To examine the effects of a larger protein load, 3 subjects performed an additional test in which 33g 
protein was added to the cream meal. 
ii) Intravenous fat tolerance tests: 
Intravenous fat tolerance testing was performed in 1 O men as described in Chapter 1. Each subject 
performed a baseline test in the morning following an overnight fast. On completion of the test, a solu-
tion comprising 25g Casilan in 300ml water was consumed, and a second test was performed 3 hours 
later. 
3) Analysis: 
Postprandial lipemia and the rate of disappearance of lntralipid (k2) was calculated as described in 
Chapter 1. The mean values for postprandial lipemia and k2 determined before and after protein inges-
tion were compared using Wilcoxons signed rank test for paired data. 
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RESULTS: 
1) Oral fat tolerance: 
Mean fasting serum TG concentration was similar before meal 1 (61.±. 17mg/dl) and meal 2 
(62.±.22mg/dl) . The shape of the curves of serum TG concentration plotted against time were similar 
a:fter both meals (see Figure 9) . Mean postprandial lipemia was slightly, but not significantly higher after 
meal 2 (213.±.112mg.dr
1 .7hr) than after meal 1 (190.±.101 mg.dr
1 .7hr, P >0.025). The mean maximum 
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Figure 9. Mean serum triglyceride concentrations of 15 normolipidemic subjects after meals contain-
ing 23g protein and 40g fat (I) and 40g fat alone (•) . 
- In the three subjects who received 33g protein, postprandial lipemia was 63, 278, and 160 mg.dr
1 .7hr 
after cream alone. The corresponding values after the ingestion protein and cream were 73, 235, and 
151 mg.dr1.7hr. 
2) Intravenous fat tolerance: 
The decay curve of plasma lntralipid concentration plotted against time was adequately fitted by a 
single exponential (mean r=0.98) . The rate of disappearance of lntralipid was similar before 
(6.4.±.1.4%/minute) and after (6.1.±.1.5%/minute) protein ingestion (P > 0.25) . 
Chapter 4. Protein ingestion and postprandial lipemia 41 
DISCUSSION: 
The results of this study indicate that acute protein ingestion does not significantly influence the de-
gree of lipemia elicited by a standard fat meal. These findings are supported by the observation that, in 
the present study, the ingestion of 23g protein did not significantly influence the rate of disappearance 
of an intravenous bolus of lntralipid, an artificial fat emulsion which models the intravascular decay 
kinetics of chylomicrons (35) . Only one previous study has examined the effects of dietary protein on 
postprandial lipemia. Sullivan (119) reported that protein ingestion augmented postprandial lipemia in 
4 out of 6 subjects. In the present study, postprandial lipemia was slightly augmented by protein inges-
tion in 8 out of 15 subjects. In the other 7 subjects. postprandial lipemia was slightly lower after meals 
containing protein and fat than after meals containing fat alone. Therefore. while the different protocols 
used in the 2 studies preclude more direct comparison, the results of these studies appear compatible. 
It is possible that the doses of protein used in this study were too small to significantly affect postpran-
dial lipemia. To evaluate this hypothesis, three subjects were challenged with a larger dose (33g) of 
protein. The larger dose clearly did not have a greater effect than did the smaller dose used in the study. 
Therefore it seem? likely that the amount of protein typically consumed in a single mixed meal does not 
significantly affect the magnitude of lipemia induced by that meal. 
· A previous study has suggested that intravenous glucagon administration may diminish postprandial 
lipemia (120). Since protein ingestion stimulates endogenous glucagon release (121), it is possible that 
dietary protein may modulate postprandial lipemia by increasing plasma glucagon concentrations. The 
results of the present study suggest that, under physiological conditions. hormonal factors (including 
glucagon) which are released in response to protein ingestion do not play a significant role in the regula-
tion of postprandial lipemia. 
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Although the relationship between dietary carbohydrate and serum TG metabolism has been exten-
sively investigated, few studies have examined the role of acute carbohydrate ingestion in regulating 
the plasma TG responses to mixed meals. In early studies, the ingestion of large quantities of car-
bohydrates {119), particularly glucose {122), appeared to reduce the magnitude of lipemia evoked by 
a fat~containing meal. Since the magnitude of postprandial lipemia is believed to be determined large-
ly by the rate of chylomicron-TG clearance (see reference 30 and Chapter 2), some investigators 
{123,124) have proposed that changes in the serum TG pool size which follow the ingestion of a mixed 
meal are actively dainped by an acute increase in the capacity of the serum TG removal mechanism(s). 
Studies in the rat have indicated that acute insulin administration increased the activity of adipose tis-
sue LPL (see 47 for review), the rate limiting enzyme for plasma TG clearance, therefore it was proposed 
that insulin released in response to glucose ingestion increased adipose tissue LPL activity and hence 
_ chylomicron-TG clearance. 
The results of several studies appear to support this hypothesis. Mann et al {124) reported lower 
postprandial plasma TG concentrations after meals containing glucose and fat than after sucrose and 
fat, and an inverse correlation was found between postprandial plasma insulin and TG concentrations. 
The ingestion of fructose, which elicits little increase in plasma insulin concentrations, may cause in-
creased rather than decreased postprandial plasma TG concentrations {123). Nilsson-Ehle {49), 
reported a direct correlation between plasma insulin concentrations and adipose tissue LPL activity 
after glucose ingestion. Carbohydrate ingestion increases adipose-tissue LPL activity in normal but not 
in diabetic men {52). 
In more recent studies, however, the importance of acute postprandial changes in plasma insulin con-
. centrations in the regulation of postprandial lipemia and plasma TG removal has been questioned. 
Nicholls et al {125) reported that 50g glucose ingestion did not diminish postprandial lipemia following 
meals containing 62g fat. Furthermore, increases in adipose tissue LPL activity may only become sig-
nificant several hours after insulin administration {50), and this effect is significantly blunted by fat in-
gestion {53).- In addition, while several studies have indicated that the administration of glucose alone 
causes increased adipose tissue LPL activity {49,126) , it appears that the ingestion of mixed meals has 
little effect on the activity of this enzyme in man {33,52) . 
• Although the acute effects of insulin on adipose-tissue LPL activity have been extensively documented 
(see 48 for review), the effects of glucose Ingestion on chylomicron-TG clearance have not been sys-
tematically studied, and the reasons for the disparate findings of previous investigations into the effects 
of glucose ingestion on postprandial lipemia are not known. 
The purpose of the present study was to investigate the role of carbohydrate ingestion and acute 
postprandial changes in plasma insulin concentrations in the regulation of postprandial lipemia. Some 
studies {123, 124) have indicated qualitative differences in the postprandial TG responses to different 
carbohydrates, but further comparison between the effects of these carbohydrates Is hampered by the 
different doses of carbohydrate and fat used, and by the different blood sampling protocols employed 
in these studies. No study has compared the effects of each of these carbohydrates examined under 
similar experimental conditions. In the present study, the effects of glucose, fructose and sucrose on 
the magnitude of lipemia evoked by a standard fat load have been compared using a randomized, lon-
gitudinal experimental design. To clarify the relationship between glucose ingestion and postprandial 
plasma TG metabolism in normolipidemic subjects a similar experimental design was employed to com-
pare the effects of two different doses of glucose on postprandial lipemia. The possible effects of glucose 
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ingestion on TG absorption were evaluated using the intravenous fat tolerance test and a duodenal fat 
perfusion. 
To determine whether the putative hypotriglyceridemic effect of glucose is more pronounced in in-
sulin-sensitive individuals, we examined the effects of glucose ingestion on postprandial lipemia in high-
ly trained male athletes, a group characterized by extreme sensitivity to the action of insulin (127). The 
possible influence of glucose ingestion on LPL-independent TG removal was investigated in 3 men with 
type I hyperlipoproteinemia due to severely defective LPL activity. 
Only one study has examined the effect of acute insulin administration on postprandial serum TG con-
centrations in man. Krut et al (128) found that the intravenous infusion of insulin in 10 percent glucose 
solution reduced postprandial lipemia (measured as serum turbidity) and chylomicron TG concentra-
tions, but that the infusion of insulin alone did not. In the present study, the effect of acute postprandial 
hyperinsulinemia on concomitant serum TG metabolism was evaluated. Since the administration of in-
sulin to healthy subjects may result in hypoglycemia, which in turn provokes the release of counter-
regulatory hormones such as adrenaline, glucagon and growth hormone, the effect of insulin alone (ie. 
without exogenous glucose) on the serum TG responses to a standardized fat meal and on the rate of 
removal (k2) of an intraveno-usly administered TG emulsion was examined in young, nor-
motriglyceridemic type I diabetics. 
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METHODS: 
1) Subjects: 
i) Sedentary subjects: 
Seventy-six medical students (57 men and 19 women) gave informed consent for this study. The sub-
jects were apparently healthy, nonobese (91), normolipidemic, nonsmokers. None performed regular 
vigorous exercise and none used oral contraception or any other medication known to affect lipid me-
tabolism. 
ii) Athletic subjects: 
Twelve men who performed at least one hour of vigorous exercise per day, and who competed regular-
ly in running or in triathlon events were recruited on the assumption that they would have increased 
sensitivity to the glucoregulatory action of insulin. This contention is supported by the observation that 
the integrated plasma insulin (80.±39mU/l.2hr) and glucose (4.0.±3.2mmol/l.2hr) responses to 75g oral 
glucose were markedly lower in these men than in a group of 12 sedentary men of similar age and 
weight (234.± 175mU/l.2hr and 8.5.±6.3mmol/l.2hr respectively) . 
iii) Type I hyperlipoproteinemic subjects: 
Three men with Type I hyperlipoproteinemia due to familial LPL deficiency were recruited from the 
Lipid Clinic at Groote Schuur Hospital. The clinical ~haracteristics of these patients have been reported 
previously (129). Although detailed dietary assessment was not attempted in this study, these subjects 
reportedly practised little or no dietary restriction, and all had marked chylomicronemia after an over-
night fast. 
iv) Type I diabetic subjects: 
Twenty insulin-dependent diabetics (11 males and 9 females) who did not smoke or drink any alcohol, 
and who had been treated with insulin for a minimum of-3 years were recruited for the study (see Table 
5 for clinical data). All of the subjects were classified as type I diabetic according to the criteria of the 
National Diabetes Data Group (130) . Diabetic control, assessed from measurements of glycosylated 
haemoglobin, was considered fair to good (see Table 5). Informed consent was obtained from all sub-
jects. Where the subjects were under 18 years of age, parental consent was also obtained. 
2) Study design: 
i) Comparison of glucose, fructose and sucrose: 
Twenty-one sedentary subjects (12 women and 9 men, see Table 6 for clinical data) were randomly 
allocated to 7 treatment sequences arranged as three 7x7 latin squares (131 ). The tests were performed 
at 3-day intervals. At 7 pm on the evening before each test, each subject received a standard meal com-
prising 4 (machine sliced) slices of white bread, 40g peanut butter, 20g jam, 500mL whole milk and 
250mL unsweetened apple juice. Thereafter, no food or drink (excepting water) was consumed until 
the commencement of the test procedure on the following day. 
Each subject reported to the laboratory at 7.30am and a blood sample was drawn without stasis from 
an antecubital vein. Subjects were seated for at least 10 minutes before, and during phlebotomy. The 
test meals were then consumed within 10 minutes. Further blood samples were drawn at 2, 4, 6 and 7 
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hours postprandial. Blood samples were allowed to clot and serum was collected by centrifugation and 
stored at -20 degrees C. 
A stock meal comprising 100ml dairy cream (40g fat), 1 level teaspoon chocolate flavouring and 
300ml water was consumed during tests 1 to 6. The ingredients were stirred together to form a readi-
ly drinkable liquid. For test 1, the stock meal was consumed without addition of carbohydrate. For test 
2, 50g glucose was added to the stock meal. Additional blood samples were drawn from 9 subjects at 
0.5, 1, and 1.5 hours postprandial. These samples were taken into tubes containing potassium oxalate 
and sodium fluoride (for glucose determination) and EDTA (for insulin assay) . For test 3, the subjects 
consumed the stock meal. Thereafter, 500ml of a 10% glucose solution was infused in 45 minutes via 
a 22 gauge catheter placed in a cubital vein. For test 4, 50g fructose was added to the stock meal, while 
for test 5, 50g sucrose was added. For test 6, 1 OOg sucrose was added to the stock meal. For test 7, 
intravenous fat tolerance was determined as described in Chapter 1. 
ii) Further investigation into the effects of glucose on postprandial lipemia: 
a) Oral fat tolerance: 
• 
Eighteen subjects -(11 men and 7 women, see Table 7 for clinical data) were randomly allocated to 3 
treatment sequences arranged as six 3x3 latin squares (131 ). Oral fat tolerance tests were performed 
at 3 day intervals as described in Chapter 1. A stock meal comprising 100ml cream ( 40g fat), 3g choco-
late flavouring and 250ml water was consumed during each test. 
For test 1, the stock meal was consumed without addition of glucose. For test 2, 50g glucose was 
added to the·stock meal. For test 3, subjects consumed the stock meal plus 50g glucose. Thirty minutes 
later, a further 50g glucose was ingested. Blood samples were drawn before, and at 2,3,4,6, and 7 hours 
after the meals. During tests 2 and 3, blood samples for plasma insulin and glucose determination were 
taken from 9 subjects before and at 0.5, 1, 1.5 and 2 hours after the meal. 
In 8 of these subjects, 2 further tests were performed using the protocol described above. The test 
meals comprised 100ml cream, 270ml water, 16.6g urea and 30ml lemon concentrate and 100ml 
cream, 300ml water and 1 OOg starch. The starch was given in two 50g doses as described for meal 3 
above. 
Oral fat tolerance was also measured in 12 athletes. Each subject was tested twice, with an interval 
of 3 days between tests. The test order was randomized. For test 1, the subjects consumed the stock 
meal described above, while for test 2, 50g glucose was added to the stock meal. During test 2, a blood 
sample for plasma insulin determination was taken 30 minutes after the ingestion of the meal. 
b) Intravenous fat tolerance: 
Intravenous fat tolerance testing was performed in 17 men, as described in Chapter 1. Each subject 
was tested 3 times, with an interval of at least 2 days between tests. The tests were performed in ran-
dom order. One test was performed after an overnight fast (IVFTT1 ). The other tests were performed 2 
hours (IVFTT2) and 4 hours (IVFTT3) after the ingestion of 50g glucose. During IVFTT2, plasma insulin 
concentrations were measured 30 minutes after glucose ingestion. 
c) lntraduodenal fat administration: 
Serum TG responses to intraduodenal fat administration were determined as described in Chapter 1 
using a fat emulsion comprising 1 OOg olive oil and 7g gum acacia per litre of water infused at a rate of 
175mg triglyceride/kg/min. Previous studies have indicated that fat in this form is efficiently absorbed 
after oral administration (92). 
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Each subject was tested twice. A baseline test was performed in which the stock emulsion only was 
given. On a another occasion, 200g glucose (20g/hour) was added to the perfusate of 1 O subjects (per-
fusion 2), while the other 10 subjects drank a solution comprising 50g glucose in 400ml water (per-
fusion 3) . The solution was given 3 hours after commencing the perfusion. The test sequence was 
randomized. 
d) Glucose feeding in type I hyperlipoproteinemic men: 
Fasting blood samples were drawn at 8.00am from 3 type I hyperlipoproteinemic men. Each drank a 
solution comprising 50g glucose in 400ml water at 8.05am and again at 8.30am. Further blood samples 
were taken at 1 o.ooam and at 12.00am. 
iii) Effects of insulin administration in Type I diabetics: 
a) Oral fat tolerance tests: 
Each subject consumed a standardized fat meal (i) 1 O minutes after insulin administration (procedure 
1), and (ii) 13 hours after insulin administration (procedure 2) . Procedures 1 and 2 were performed in 
randomized order, and were separated by a 7 day interval. In 13 subjects, the test meals comprised 
100ml dairy cream (40g fat) diluted with 100ml water. In 7 subjects, the test meals comprised 40ml 
olive oil in 160ml skimmed milk. Blood samples were collected 1 o minutes before the meal and then 
at 1 hour intervals for 5 hours after the meal. Blood was collected into plain tubes for the measurement 
of TG ; perchloric acid for the measurement of acetoacetate and beta-hydroxybutyrate; EDTA and 
aprotinin (Trasylol) for the measurement of glucagon and growth hormone; potassium oxalate and 
sodium fluoride for the measurement of glucose and glycosylated haemoglobin. During the test, the 
glucose concentrations of the hourly blood samples were measured using an Ames glucometer. Where 
necessary, hypoglycemia was prevented by the administration of glucose sweets. 
b) Intravenous fat tolerance tests: 
Intravenous fat tolerance was measured in 9 subjects (i) 2 hours after insulin administration (proce-
dure 3) and (ii) 13 hours after insulin administration (procedure 4) . 
c) Insulin administration: 
During procedures 1 and 3, the subjects received their usual morning dose of insulin by subcutaneous 
injection (see Table 5). All subjects used combinations of fast-acting (Actrapid) and crystalline 
{Monotard) insulin preparations. In a preliminary study of 5 of these subjects, plasma free insulin con-
centrations were measured using the method of Nakagawa ( 132) before, and at 1, 2, and 3 hours after 
insulin administration. 
3) Analysis of samples: 
Serum TG lntralipid-TG, cholesterol, HDL-cholesterol, glucose and insulin concentrations were deter-
mined as described in Chapter 1. Samples from the hyperlipoproteinemic subjects were diluted 1 o fold 
with normal saline before assay. Plasma glucagon concentrations were determined by radioimmunoas-
say with an antibody (V13) which is specific for the C-terminus of glucagon. Beta-hydroxybutyrate (133) 
and acetoacetate (134) were assayed enzymatically. Glycosylated haemoglobin was assayed by 
column chromatography (Test Combination 556742, Boehringer Mannheim). 
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4) Analysis of Data: 
i) Postprandial lipemia: 
Two indices of postprandial lipemia were calculated from the postprandial serum TG measurements: 
Total postprandial lipemia was calculated by numerical integration of the area under the curve described 
by serum TG concentrations plotted against time (Chapter 1). The maximum increment in serum TG 
concentration was calculated from the difference between the maximum postprandial TG concentra-
tion and the fasting serum TG concentration. 
ii) Intravenous fat tolerance: 
The rate of disappearance of lntralipid (k2) was determined from the monoexponential decay curve 
of plasma lntralipid concentrations as described in Chapter 1. 
iii) Statistical methods: 
a) Analysis of Latin Square design: 
. These data were compared using analysis of variance (ANOVA) after a normal probability plot of the 
residuals revealed no evidence of non-normality or serious heteroscedasticity. The blocking variables 
were SUBJECT and ORDER POSITION OF THE TREATMENT. After the preliminary F-test indicated the 
variable TREATMENT to be significant, differences between treatments were investigated using the 
Ryan-Einot-Gabriel-Welsch (REGW) multiple F-test. This test is considered to be more powerful than 
traditional simultaneous procedures such as Tukey's method (135). 
b) Other analyses: 
The mean plasma insulin concentrations measured 30 minutes after meal 2 in athletes and in seden-
tary men were compared using an unpaired t-test. All other parameters were compared using the paired 
t-test (95). Where the mean values of repeated measures were compared, the level of probability was 
adjusted using Bonferroni's procedure (135) . 
The correlation between the insulin response to meals containing glucose and the hypotriglyceridemic 
effect of glucose (calculated as the difference in postprandial lipemia between meals containing glucose 
and fat and those containing fat alone) was estimated from the sample correlation coefficient (95). 
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RESULTS: 
In general , the test procedures were well tolerated except for a slight, transient dizziness reported by 
most subjects 2 hours after the intravenous glucose infusion. No subject was nauseated or had diar-
rhoea during or after any of the tests. 
i) Comparison of glucose, fructose and sucrose: 
The ANOVA showed the blocking variable SUBJECT and the variable TREATMENT to be highly sig-
nificant (P <0.0001) . The variable ORDER POSITION OF THE TREATMENT was not significant (P >0.6) . 
Fasting TG concentration fitted as a co-variate was not significant (P > 0.8) . The REGW procedure 
showed no significant effect of oral or intravenous glucose administration or of 50g sucrose ingestion 
on total postprandial lipemia or on the maximum postprandial serum TG increment above the fasting 
value (see Table 8) . The addition of 50g fructose, or of 1 OOg sucrose, to the stock meal resulted in sig-
nificantly greater postprandial lipemia, and significantly higher maximum serum TG increments than 
did the ingestion of fat alone, however. 
Table 7. Clinical data of the 21 subjects in this study in whom 5 different carbohydrate treatments 
were compared. 
Men Women 
Age (yr) 20.±3 19.±1 
Weight (kg) 74.±7 59.±8 
Height (cm) 181.±8 167.±5 
% Body fat 13.±2 22.±2 
FTC (mg/dl) 177.±21 190.±31 
HDL-C (mg/dl) 58.±10 63.±9 
HDL2-C (mg/dl) 15.±10 21.±10 
Abbreviations: FTC= fasting total cholesterol, HDL-C = high-density 
-
lipoprotein cholesterol , HDL2-C = high-density lipoprotein 
subtraction 2 cholesterol. Each value represents the mean.± the standard deviation 
Table 8. Effects of 5 different carbohydrate treatments on the serum triglyceride responses to a 
meal containing 40g fat. 
Grouping Treatment Mean PPL Mean PPI 
(mg .. dL"1.7hr) (mg/dl) 
A 50g Fructose 374.±186 94.±46 
A 1 OOg Sucrose 334.±168 85.±41 
B A 50g Glucose (IV) 314.±149 76.±39 
B C 50g Sucrose 243.±118 63.±28 
B C Stock Meal 214.±110 56.±29 
C 50g Glucose (Oral) 187.±109 50.±24 
Key: Each value represents the mean.± the standard deviation for 9 males and 12 females. Treatments 
covered by the same grouping letter are not significantly different (Ryan-Einot-Gabriel-Welsch Multiple 
F-test). 
Abbreviations:PPL = total postprandial lipemia, PPI = maximum postprandial triglyceride increment. 
Chapter 5. Carbohydrates. insulin, and postprandial lipemia 49 
ii) Further investigation into the effects of glucose: 
a) Oral fat tolerance: 
The mean ages and anthropometric data of the sedentary subjects are given in Table 9. 
Table 9. Age and anthropometric data of 18 normolipidemic men and women in whom the ef-
fects of 50 and 100g glucose were studied. 
Men Women 
(n=11) (n=7) 
AGE (years) 22..±..3 19..±..0.5 
HEIGHT (cm) 178..±..5 166_±_4 
WEIGHT (kg) 72..±..10 54±3 
%B0DYFAT 14..±..3 22..±..3 
Values are means_±_standard deviations. -
In the sedentary subjects fasting serum TG concentration was similar before each test (see Table 10). 
Mean postprandial lipemia was lower after the glucose-containing meals than after cream alone, but 
the responses to glucose were quite variable between individuals and were therefore not statistically 
significant at the 5% level. In 7 out of 18 subjects, postprandial lipemia was higher after meals contain-
ing 50g glucose and cream than after cream alone. The mean maximum TG increase above the fast-
ing value was significantly lower after meals containing glucose and cream than after meals containing 
cream alone. 
Table 1 o. Plasma insulin and triglyceride responses of sedentary subjects to meals containing 
different proportions of glucose and fat. 
Meal 1 Meal 2 Meal 3 
(40g fat) (40g fat + {40g fat + 
50g glucose) 1-009 glucose) 
FTG 80..±..28 76.±.31 74..±..28 
PPL 171..±..104 130..±..106 105..±..76 
PTG 124.±.39 104.±.40a 102.±.41a 
TG2 124.±.39 98.±.45a 83..±..43a 
Fl 9.±.3 10.±.5 9.±.2 
IR 27..±..5 231..±..112 445..±..243 
All triglyceride data are means.±.standard deviations of 18 subjects. Insulin data are means.±.standard 
deviations of 9 subjects for meals 2 and 3 and 3 subjects for Meal 1. 
Abbreviations and units: FTG = fasting serum triglyceride concentration (mg/dL), PPL= postpran-
dial lipemia (mg.dL-1. 7hr), PTG = peak serum triglyceride concentration (mg/dL), TG2 = serum 
triglyceride concentration 2 hours after the meal (mg/dL), Fl =fasting plasma insulin concentration 
(mU/L) , IR= integrated insulin response (mUr
1 .2hr) 
a= P.05 calculated using Ryan-Einot-Gabriel-Welsch multiple F test. 
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The mean maximum increment in serum TG concentration occurred 2 hours after cream alone, 4 
hours after cream+ 50g glucose, and 6 hours after cream + 1 OOg glucose (see Figure 10). The integrated 
plasma insulin concentrations were not significantly correlated with the effect of glucose on postpran-
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Figure 1 o. Mean serum triglyceride concentrations after meals containing 40g fat (t}. 40g fat + 50g 
glucose (e), and 40g fat + 100g glucose in 18 sedentary, normolipidemic subjects (11 men and 7 
women). * = P < 0.05 (Ryan-Einot-Gabriel-Welsch test). 
Fasting serum TG concentrations and postprandial lipemia measured before meals containing urea 
and cream or starch and cream were not significantly different from the corresponding values measured 
during meals containing cream alone (see Table 11). The mean serum TG concentration measured 2 
hours after the meal, and the mean maximum increase in serum TG concentration (above the fasting 
value) were lower after meals containing urea and cream than after cream alone. 
Table 11. Serum triglyceride responses to meals containing cream alone (CRE), urea+ cream 
(URE), and starch+ cream (STA). 
CRE URE STA 
FTG 72.±.28 78.±.18 80.±.28 
TG(2hr) 123.±.23 103.±.27a 119.±.31 
PPL 168.±.108 133.±.71 159.±.46 
PPl(max) 58.±.28 49±.22 50.±.21 
Abbreviations and units: FTG =fasting triglyceride concentration (mg/dl), TG(2hr) =triglyceride con-
centration 2 hours after the meal (mg/dl), PPL=postprandial lipemia (mg.dL-
1.?hr) 
a=P.05 
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Figure 11 . Mean serum triglyceride concentrations of 8 normolipidemic subjects after the ingestion of 
40g fat (t); 40g fat + 50g glucose •. and 40g fat + 16.6g urea (e). 
The addition of 1 OOg starch to the stock meal did not significantly affect any of these parameters (see-
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Figure 12. Mean serum triglyceride concentrations of 8 normolipidemic subjects after the ingestion 
of 40g fat (e). 40g fat+ 1 OOg glucose ~), and 40g fat + 1 OOg starch ct}. 
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In the athletes, the mean fasting serum TG concentration was 62.±28mg/dl before cream ingestion, 
and 68.±23mg/dl before ingestion of cream + glucose (P > 0.5) . Mean postprandial lipemia was slight-
ly but not significantly lower after meals containing cream + glucose (108.±84mg.dL-
1.7hr} than after 
meals containing cream alone (139.±64mg.dL-
1.7hr, P > 0.1). 
The mean plasma insulin concentration measured 30 minutes after cream+ glucose was significant-
ly lower in athletes than in sedentary men (27 .±8 versus 56.±28mU/L, P < 0.001 ). 
b) Intravenous fat tolerance: 
The mean fractional removal rate (k2) of lntralipid measured 2 hours (4.5.± 1.4%/min) or 4 hours 
(4.6.±1 .5%/min) after glucose ingestion did not differ significantly from the rate determined underfast-
ing conditions (5.0.±1 .3%/min, P > 0.05, see Figure 13}. Mean plasma insulin concentrations increased 
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- Figure 13. Mean serum optical density after lntralipid injection in 17 normolipidemic men before (II), 
and 2 hours after (e) 50g glucose ingestion. 
c) Chylomicron-TG clearance 
During the baseline duodenal perfusion tests (in which no glucose was given) plasma TG concentra-
tions remained constant between 5 and 1 O hours after commencement of the infusion (see Figure 14). 
Mean variation around the steady state value was 13%. Glucose administration, whether orally or by 
duodenal perfusion, resulted in a gradual decline in plasma TG concentrations during the 5 hour measur-
ing period. The mean plasma TG concentrations of the hourly samples drawn during the baseline study 
were compared with those drawn at the corresponding times during perfusions 2 and 3. Mean plasma 
TG concentrations were slightly lower during perfusions 2 and 3 than during the baseline perfusion, but 
these differences only became significant after 9 hours during perfusion 2 and after 8 hours during per-· 
fusion 3. 
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Figure 14. Mean serum triglyceride concentration of 10 men during duodenal perfusion with 10% olive 
oil (q , and 10% olive oil + 20g glucose/hour. * = P < 0.05 (paired t-test) . 
d) Type I hyperlipoproteinemic men: 
All samples drawn from the type I hyperlipoproteinemic men were grossly lipemic, and a thick, creamy 
layer formed in samples allowed to stand overnight. Serum TG concentrations decreased slightly during 
the course of the test (see Table 12). 
Table 12. Fasting and postprandial serum triglyceride concentrations in 3 men with type I hyper-
lipoproteinemia. -
FTG TG2 TG4 
1 2347 2253 2385 
~ 4600 4300 4400 
3 2972 2877 2536 
Abbreviations and units: FTG = fasting triglyceride concentration (mg/di), TG2 = triglyceride concentra-
tion 2 hours after glucose ingestion (mg/dl), TG4 = triglyceride concentration 4 hours after glucose in-
gestion (mg/dl). 
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iii) Effects of insulin administration in Type I diabetics: 
Ages and anthropometric data of the diabetic subjects are given in Table 13. 
Table 13. Age, anthropometry and clinical data of male and female Type I diabetics. 
Males Females 
(n = 11) (n =9) 
Height (cm) 173.±. 4 157 _±_7 
Weight (kg) 67.±.8 62_±_7 
% Bodyfat* 14_±_2 30_±_4 
Age (yr) 18.±.3 19.±.2 
Duration 6.±.3 8.±.3 
Treatment (Units/Day) 74_±_24 46.±.8 
HbA1 (%)** 12_±_2 11 _±_2 
SerumCholesterol (mg/dL) 200.±.27 208.±.24 
HDL-Cholesterol (mg/dL) 64.±.6 65.±.8 -
* Estimated from skinfold thickness 
** Normal reference range of this laboratory is 5.5-8.5% 
a) Oral fat tolerance: 
Serum TG responses to olive oil were similar to those measured after cream feeding, therefore the 
data from these studies were pooled. The mean values of the parameters measured in these studies 
are given in Table 14. 
Table14. Fasting metabolite and hormone concentrations and postprandial lipemia in Type I 
diabetics. 
Procedure 1 Procedure 2 
GLU 15_±_7 15_±_5 
BHB 468.±.369 460.±.572 
AA 194.±.122 109_±_90 
IRG 89.±.27 97_±_33 
HGH 4.±.4 5_±_5 
FTG 71_±_33 68.±.31 
PPL 2.91_±_2.02 2.46_±_ 1. 77 
Abbreviations and units:GLU = glucose (mmol/L), BHB = beta- hydroxybutyrate (micromol/L), 
AA= aceto-acetate (micromol/L), IRG = glucagon (ng/L), HGH = growth hormone (µg/L), FTG = fasting 
triglyceride (mg/dL), PPL= postprandial lipemia (mg.dL-1.5hr) . 
Glucose and ketone body concentrations: 
All subjects were hyperglycemic at the start of each test (see Table 12). Fasting ketone body con-
centrations were higher than would be expected for a fasted, non-diabetic population (136) but no sub-
ject was ketoacidotic, nor did any subject become ketoacidotic during the course of any of the test 
procedures. After insulin administration, plasma glucose and beta-hydroxybutyrate concentrations fell 
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sharply in all subjects (see Figures 15 & 16), generally reaching a nadir within 1 to 3 hours. No subject 
Ingested more than 7g glucose, and none complained of hypoglycemic symptoms. In the studies In 
which no insulin was given, mean glucose and beta-hydroxybutyrate concentrations rose gradually 
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Figure 15. Blood Beta-Hydroxybutyrate responses to fat ingestion in diabetic patients with (0) and 
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Figure 16. Blood glucose responses to fat ingestion in diabetic patients with (Q and without (e) con-
comitant insulin administration. 
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Glucagon and growth hormone concentrations: 
56 
In all subjects, fasting plasma glucagon concentrations were within the normal reference range (ng/L) 
of our laboratory (see Table 12). During procedure 1, mean plasma glucagon concentration decreased 
(average decline = 41%), generally reaching a nadir within 3 hours following insulin administration. 
During procedure 2, mean plasma glucagon concentration increased slightly (average increase = 34%) 
during the first three hours of the test, but decreased towards fasting values thereafter. 
The mean fasting plasma growth hormone concentration was within the normal reference range 
(microgram/L) although 3 subjects had moderately elevated (less than 2-fold) fasting concentrations 
of this hormone. Plasma growth hormone concentrations did not vary consistently during either of the 
test procedures. 
Serum TG concentrations: 
The mean fasting serum TG concentration and the mean magnitude of postprandial lipemia was not 
significantly different between procedures 1 and 2 (see Figure 17 and Table 12). This result was ob-
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Figure 17. Serum triglyceride responses to fat ingestion in diabetic patients with (o) and without (e) 
concomitant insulin administration. 
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b) Intravenous fat tolerance: 
57 
Mean k2 for TG removal was slightly but not significantly lower after procedure 3 (5.3.±5%/min) than 















0 5 10 15 20 25 30 35 
Time (min) 
Figure 18. Plasma optical density after lntralipid administration in diabetic patients with '- and without 
(II) concomitant insulin administration. 
c) Plasma free insulin: 
Before insulin administration, the mean plasma free insulin concentration of 5 diabetic patients was 
11.±7mU/L. In our laboratory, the normal reference range for fasting, non-diabetic men is 2-20mU/I. 
Within 1 hour after insulin injection, plasma free insulin concentrations were substantially increased in 
all subjects (mean =33.±8mU/L). Mean plasma free insulin concentrations rose progressively during 
the 3 hour measuring period, reaching a peak concentration of 41.± 1 OmU/IL 3 hours after insulin injec-
tion. 
Chapter 5. Carbohydrates, insulin, and postprandial lipemia 58 
DISCUSSION 
The results of this study indicate that the serum TG responses to a mixed meal may vary significant-
ly according to the amount and type of carbohydrate present in the meal. In the normolipidemic in-
dividuals who comprised the present study sample, the effects of carbohydrate ingestion appeared to 
be independent of fasting serum TG concentrations. 
I) Fructose and sucrose administration: 
In the present study, postprandial lipemia was significantly increased by the addition of 50g fructose, 
or of 100g sucrose to the stock meal. The addition of 50g sucrose to the stock meal did not augment 
postprandial serum TG concentrations. A similar effect of fructose has been described previously (123). 
Two previous studies have examined the effects of sucrose on postprandial lipemia. Mann et al (124) 
found that meals containing glucose and fat evoked less postprandial lipemia than did meals contain-
ing sucrose and fat. Since no control data from meals comprising fat alone were reported, it is not clear 
whether this difference was due to a hypotriglyceridemic effect of glucose or to a hypertriglyceridemic 
effect of sucrose. Sullivan et al (137) reported that the ingestion of 1 OOg sucrose did not significantly 
affect mean postprandial serum TG concentration measured 4 hours after the ingestion of 1 OOg peanut 
butter. In the present study, mean serum TG concentration measured 4 hours after the meal was 
124.±. 46mg/dL after the ingestion of cream alone and 132.±. 42mg/dL (P0.2) after the ingestion of cream 
and 1 OOg sucrose. 
Accordingly, if the serum TG concentration measured 4 hours after the meal was considered to rep-
resent postprandial lipemia then our data would be consistent with those of Sullivan et al (137). In the 
present study, mean serum TG concentrations were higher at 6 hours (88.±.33mg/dL vs 136.±.62mg/dL, 
P < 0.001 ), and at 7 hours (77.±.23mg/dL vs 93.±.30mg/dL) after the ingestion of 100g sucrose and 
cream than after the ingestion of cream alone. Therefore the increased postprandial lipemia caused by 
sucrose ingestion reflects a late rise (more than 4 hours after the meal) in serum TG concentrations. 
Although the hypertriglyceridemic effect of sucrose is usually ascribed to the fructose component, 
Thompson et al (138) have reported that postprandial plasma TG concentrations are higher after chronic 
sucrose ingestion than after the ingestion of equivalent quantities of glucose and fructose, the monosac-
charide components of sucrose. The role of this disaccharide effect of sucrose in the present study 
cannot be directly evaluated as the effects of glucose and fructose fed simultaneously as monomers 
were not studied. Since glucose ingestion did not appearto affect the magnitude of postprandial lipemia, 
and since the increment In postprandial lipemla induced by the ingestion of 1 OOg sucrose was quan-
titatively similar to that induced by 50g fructose, it seems reasonable to propose that the effect of sucrose 
observed In the present study was due to the fructose component. 
Increased lipemia may have been caused by reduced clearance of TG or by increased TG influx into 
blood. While it is possible that fructose and sucrose may have reduced TG clearance, there Is little 
evidence to support this hypothesis. Acute impairment of the TG removal system seems unlikely, as 
fructose appears to stimulate adipose-tissue LPL (54). An alternative, and more likely explanation is that 
fructose may have increased the influx of TG into blood. An increase in TG influx would presumably 
comprise an increased endogenous TG component, since dietary TG is almost completely absorbed 
in normal subjects (85). 
ii) Glucose administration: 
The results of the comparative study indicate that the ingestion of 50g glucose does not significantly 
diminish postprandial lipemia. These data suggest that acute postprandial changes in plasma insulin 
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concentrations do not regulate postprandial lipemia. This hypothesis is supported by the further obser-
vation that the intravenous administration of 50g glucose caused a moderate increase rather than a 
decrease in postprandial serum TG concentrations. 
To evaluate this hypothesis further, additional oral fat tolerance tests were performed. The results of 
these studies indicate that glucose ingestion does influence postprandial serum TG concentrations, but 
that these effects are largely due to changes in TG absorption, rather than TG clearance. Glucose in-
gestion {50 and 1 OOg) significantly reduced the peak postprandial serum TG concentration and the 
serum TG concentrations measured 2 hours after the meals. 
Total postprandial lipemia was not significantly reduced by glucose ingestion, despite substantial 
postprandial increments in plasma insulin concentrations. While the mean postprandial lipemia was 
lower after both glucose-containing meals than after cream alone, a significant proportion of the sub-
jects had higher postprandial lipemia after ingesting glucose and cream than after cream alone. Al-
though it might be argued that a more consistent result would have been obtained using a larger sample 
size, a similar proportion (7 out of 21) of the subjects in the comparative study did not exhibit diminished 
postprandial lipemia in response to glucose ingestion. Accordingly, the present data support and ex-
tend the findings of a previous study {125) in which postprandial lipemia was not diminished by the in-
gestion of 50g glucose or by the intravenous administration of 25g glucose. 
The results of the present study also help to clarify the disparity between previous investigations into 
the effects of glucose ingestion on postprandial lipemia. Albrink et al {120) reported that the ingestion 
of large quantities (up to 250g) of glucose abolished the postprandial lipemia induced by a fatty meal. 
This conclusion was based on the comparison of plasma TG concentrations measured 3 hours after 
meals containing glucose and fat, or fat alone. Since it was assumed that serum TG concentrations 
were maximally elevated 3 hours postprandially, and that glucose ingestion did not affect the rate of 
TG absorption, the finding that glucose ingestion diminished or abolished the 3-hour rise In plasma TG 
concentrations was considered to indicate increased clearance of plasma TG. 
In the present study, peak serum TG concentrations were reached 2 hours after the ingestion of the 
meal 1 {40g fat only), and the mean serum TG concentrations were significantly lower 2 hours after 
meal 2 {50g glucose + 40g fat) and meal 3 {100g glucose + 40g fat) than after meal 1. Therefore if 
serum TG concentrations measured at this time point were used as an index of postprandial lipemia 
then the present findings would be consistent with those of Albrink et al {120) . Peak serum TG con-
centrations were reached 4 hours after meal 2 and 6 hours after meal 3, however. These data suggest 
that the effects of glucose on serum TG concentrations measured 2 hours (in the present study) or 3 
hours {122) after fat ingestion are the result of delayed TG absorption, rather than increased TG 
clearance. 
This hypothesis is supported by the observation that the rate of clearance of intravenously ad-
ministered lntralipid was not increased at 2 hours or at 4 hours after glucose ingestion. 
Three caveats need to be considered here: 
i) lntralipid kinetics may not reflect the intravascular behaviour of chylomicrons and VLDL, and may 
be independent of LPL activity. This possibility seems unlikely, as previous studies have indicated that 
lntralipid particles have clearance properties similar to those of chylomicrons {35,139) and VLDL (140), 
and the rate of disappearance of an intravenous bolus of lntralipid appears to be related to LPL activity 
{141 ). 
ii) The intravenous fat tolerance test may not be sufficlently sensitive to detect glucose-induced in-
creases in TG clearing capacity. In a previous study, however, small, heparin-induced changes in the 
rate of plasma TG clearance which reduced endogenous serum TG concentrations by as little as 12% 
Chapter 5. Carbohydrates, insulin, and postprandial lipemia 60 
were clearly detected by the intravenous fat tolerance test (see Chapter 2). Furthermore, this test has 
indicated differences in TG clearance between normolipidemic men and women (142), and between 
athletes and sedentary men (143). Increased TG clearance after moderate intensity acute exercise has 
also been demonstrated using this method (90) . Therefore it seems likely that an increase in TG dear-
ing capacity of sufficient magnitude to abolish postprandial lipemia would also result in a measurable 
increase in the fractional clearance rate of lntralipid. 
iii) The rate of clearance of chylomicron-TG is partly determined by chylomicron structure (38,144), 
and it is possible that chylomicrons synthesised after the concomitant ingestion of glucose and fat may 
be more susceptible to enzymic degradation, or to hepatic uptake, than those synthesised after the in-
gestion of fat alone. Since the intravenous fat tolerance test involves the administration of a standard 
fat emulsion, changes In TG clearance which occur as a consequence of altered chylomicron structure 
would not be detected by this method. To evaluate the Importance of putative glucose-induced chan-
ges in chylomicron structure, we measured the effects of constant intraduodenal glucose administra-
tion (20g/hour) on plasma-TG and chylomicron-TG concentrations during duodenal perfusion with a 
fat emulsion. Since glucose administration in this manner did not significantly diminish plasma or 
chylomicron-TG concentrations for at least 8 hours, it seems unlikely that glucose-induced alterations 
in chylomicron structure can account for the effects of glucose ingestion on the serum TG concentra-
tions measured 2 to 3 hours after the ingestion of a fat meal. 
To investigate the possibility that glucose ingestion augments chylomicron-TG clearance by a 
mechanlsm(s) independent of LPL, we measured the serum TG responses to 100g glucose ingestion 
in 3 men with familial LPL deficiency. These men had florid chylomicronemia on fasting, and no ex-
ogenous fat was administered during the test. In each case, serum TG concentrations were slightly 
reduced after glucose ingestion but the average decrease did not exceed 6 percent. Accordingly, it 
seems unlikely that the early effects of glucose ingestion on postprandial lipemia reflect an increase in 
LPL-independent chylomicron-TG removal. 
Given these considerations, it seems probable that glucose ingestion does not significantly increase 
the rate of chylomicron-TG clearance during the early postprandial phase. Accordingly, the effects of 
glucose ingestion on the serum TG concentrations measured during this period presumably reflect a 
decrease in the rate of TG absorption. Previous investigators (125) have suggested that glucose inges-
tion may slow TG absorption by delaying gastric emptying. To examine this hypothesis, we eliminated 
variation due to changes in gastric emptying rate by administering fat intraduodenally. Under these con-
ditions, oral glucose administration did not significantly diminish postprandial plasma TG concentra-
tions during the early phase of the perfusion (for at least 4 hours after glucose ingestion). This finding 
indicates that the early effects of glucose ingestion on postprandial lipemia can be largely attributed to 
glucose-induced changes in the rate of gastric emptying. 
To elucidate the mechanism whereby glucose delays the release of fat from the stomach, the relative 
importance of the osmotic and metabolic effects of glucose was examined. In the present study, the· 
osmotic effects of glucose were excluded by substituting an equivalent quantity of starch for glucose 
in the test meal. Our data indicate that the ingestion of 100g starch does not influence postprandial 
serum TG concentrations. Since starch is digested to glucose before being absorbed from the small 
intestine, it seems likely that these carbohydrates would have similar metabolic effects after oral ad-
ministration. Therefore the observation that starch Ingestion does not duplicate the effects of glucose 
on postprandial serum TG concentrations suggests that these effects are related to the osmotic proper-
ties of glucose rather than to a metabolic effect. This finding is consistent with the observation that 50g 
glucose given intravenously did not reduce peak postprandial serum TG concentrations, total postpran-
dial lipemia or the serum TG concentration measured 2 hours after the meal. 
If this hypothesis is true then it should be possible to reproduce the effects of glucose on postpran-
dial serum TG concentrations by increasing the osmolality of the stock meal with a metabolically inert 
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substance. In the present study, the addition of urea to the stock meal (in a dose osmotically equivalent 
to 50g glucose) caused a significant decrease in the peak postprandial serum TG concentration and in 
the serum TG concentration measured 2 hours after the meal. The peak postprandial serum TG con-
centration was delayed by urea ingestion, but total postprandial lipemia was not significantly reduced. 
These data provide further support for the contention that glucose delays the gastric emptying of fat 
by increasing the osmolality of the test meal rather than by a metabolic effect. 
Glucose administration (both by oral and duodenal route) resulted in significantly diminished serum 
TG concentrations during the latter part of the duodenal perfusion. This observation could reflect a 
gradual, progressive increase in TG clearance, a progressive decrease In the rate of TG absorption, or 
a combination of both processes. The physiological significance of this finding is not clear, since, at 
the corresponding times after oral administration, serum TG concentrations had returned to near fast-
ing levels. Accordingly, further investigation of this phenomenon was not undertaken. 
Effects of insulin on postprandial lipemia: 
In the present study, the effects of glucose ingestion on postprandial lipemia and on plasma insulin 
concentrations were not significantly correlated. These results are at variance with those of a previous 
study (124), in which postprandial lipemia was found to be inversely related to postprandial plasma in-
sulin concentrations. Those authors proposed that in subjects with high postprandial plasma insulin 
concentrations, adipose-tissue LPL activity, and thus chylomicron-TG clearance would be greatly in-
creased. 
This hypothesis is unlikely to be correct for the following reasons: 
i) In the present study, acute increments in plasma insulin concentrations did not result in increased 
clearance of lntralipid, or decreased chylomicron-TG concentrations during duodenal fat perfusion. 
ii) Previous studies have indicated that adipose-tissue LPL activity shows little (33) or no (52) response 
to the ingestion of a mixed meal. Furthermore, Sadur et al (53) have found that fat ingestion abolishes 
the insulin-induced increment in adipose- tissue LPL activity. 
iii) Adipose-tissue LPL activity is not significantly increased for at least 3 hours after insulin administra-
tion (50). 
More recently, Bazelmans et al (145) reported that the decrease in plasma TG concentrations which 
occurs following insulin administration appears to be directly related to insulin sensitivity. Accordingly, 
it is possible that the postprandial hypotriglyceridemic effects of glucose may be more apparent in in-
sulin-sensitive individuals. In the present study, glucose ingestion did not significantly reduce postpran-
dial lipemia in endurance-trained athletes, a group characterized by extreme sensitivity to the 
glucoregulatory action of insulin (127). 
On the basis of these findings, it seems unlikely that acute postprandial changes in plasma insulin 
concentrations play a significant role in the regulation of chylomicron-TG clearance or of postprandial 
lipemia. To further clarify the effects of acute hyperinsulinemia on postprandial TG metabolism, the ef-
fects of exogenous Insulin administration were studied In young type I diabetic subjects. This model 
was chosen in order to avoid the confounding variables of exogenous glucose and endogenous 
counter-regulatory hormones which are of necessity associated with insulin administration in non-
diabetic men. The well-known actions of insulin on glucose and lipid metabolism were clearly apparent 
as shown by the prompt decreases in blood glucose and ketone body concentrations which followed 
insulin administration. Measurements of plasma glucose, glucagon and growth hormone concentra-
tions suggested that euglycemia was maintained without increased counter-regulatory hormone ac-
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tion. Neither the rate of exogenous TG removal, nor the magnitude of postprandial lipemia was affected 
by insulin administration, however. These findings indicate that acute postprandial hyperinsulinemia 
does not stimulate chylomicron-TG removal in type I diabetics. 
In order to extrapolate from the insulin-dependent diabetic to the non-diabetic state, several impor-
tant caveats must be considered : 
1) In the insulin-treated type I diabetic, insulin is assimilated into the bloodstream from a peripheral 
injection site and the portal-peripheral insulin gradient which occurs under conditions of endogenous 
insulin secretion does not arise. To achieve adequate insulinization of the liver, large doses of insulin 
must be administered, and the peripheral tissues may be exposed to conditions of relative hyperin-
sulinemia (146). It could be argued, therefore, that the insulin-sensitive components of the TG removal 
system may always be maximally stimulated in insulin-treated diabetics, and that insensitivity to acute 
fluctuations in serum insulin concentrations would be expected in these subjects. This possibility seems 
unlikely, since adipose tissue LPL activity is usually within the normal range in insulin-treated diabetic 
patients (141) and LPL activity can be increased by acute insulin administration in these patients (147). 
2) Since serum TG concentrations are also determined by the rate of TG influx into the intravascular 
compartment, the possibility that TG absorption differs under conditions of insulin withdrawal and reple-
tion must also be considered. If TG absorption is delayed or incomplete under conditions of insulin 
withdrawal then the magnitude of postprandial lipemia measured in the present study might have been 
an underestimate of the true value. Although TG absorption was not directly measured in this study, 
impaired absorption seems unlikely for the following reasons: 
i) The magnitude of postprandial lipemia measured during insulin withdrawal (procedure 2) was similar 
to that observed previously in studies of nondiabetic men and women fed 1 OOmL dairy cream under 
similar conditions to those of the present study (see Chapter 3 and reference 96) 
ii) No subject was nauseated or had diarrhoea . . 
iii) During insulin withdrawal maximum serum TG concentrations were reached within 3 hours follow-
ing fat feeding. Five hours postprandially, mean serum TG concentration had returned to baseline levels. 
Furthermore, the apparent absence of an insulin-mediated effect on postprandial lipemia is supported 
by the finding that acute insulin administration did not increase the rate of removal of an intravenous-
ly injected TG emulsion, a result which cannot be ascribed to differences in gastro-intestinal factors. 
3) It is difficult to determine the dose of insulin which, when administered to a type I diabetic patient 
will be functionally equivalent to the insulin response to a given glucose load in a non-diabetic man, 
and it might be argued that such an equivalence was not demonstrably attained in these subjects. This 
question of dose-equivalence may be further confounded l:}y the presence of insulin resistance in type 
I diabetic patients (148). Since the doses of insulin which are required to maintain good glycemic con-
trol in type I diabetic patients tend to produce high peripheral insulin concentrations, each subject was 
treated with his or her regular insulin dosage on the assumption that this dosage would produce suffi-
ciently increased serum free insulin concentrations to simulate the hyperinsulinemic state which prevails 
after oral glucose administration in non-diabetic men .. pa This contention is supported by the observa-
tion that the mean peak plasma free insulin concentration measured after exogenous insulin administra-
tion in 5 of the patients in the present study (41.±10mU/1) was comparable to the mean peak plasma 
insulin concentration (58.±23mU/1) measured previously in non-diabetic subjects after ingestion of 50g 
glucose (94). 
Given these considerations, it seems likely that the results of the present study are also applicable to 
non-diabetic populations. The finding that exogenous insulin administration failed to stimulate 
Chapter 5. Carbohydrates, insulin, and postprandial lipemia 63 
chylomicron-TG removal in diabetics is consistent with the observation that the administration of 
glucose (by oral or intravenous route) does not diminish postprandial lipemia in non-diabetic subjects, 
despite substantial postprandial increments in plasma insulin concentrations. Therefore it seems 
reasonable to propose that acute physiological changes in postprandial plasma insulin concentrations 
such as those which might occur after the ingestion of a mixed meal do not significantly affect the rate 
of removal of chylomicron-TG in normolipidemic man. 
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CHAPTER 6: THE EFFECTS OF CHRONIC ENDURANCE EXERCISE TRAINING 
ON POSTPRANDIAL LIPEMIA AND CHYLOMICRON 
TRIGLYCERIDE CLEARANCE 
INTRODUCTION: 
Several studies have indicated that exercise training reduces fasting serum TG concentrations in nor-
molipidemic and in hypertriglyceridemic men (reviewed in ref 149). The effects of exercise training on 
postprandial TG metabolism have not been extensively documented, however. In a longitudinal study 
of 2 subjects, Patsch et al (75) found that exercise training lowered the serum TG response to a fatty 
meal (postprandial lipemia). These data suggest that chronic exercise may increase the rate of 
chylomicron-TG clearance. Furthermore, although chylomicron clearance has not been directly quan-
titated in endurance athletes, Ericsson et al (143) have shown that the clearance of an intravenously in-
jected fat emulsion is faster in runners than in sedentary men. Chronic exercise may also improve 
intravenous fat tolerance in hypertriglyceridemic men (150). 
Chylomicron-TG clearance and postprandial lipemia have been shown to be directly related to the 
fasting serum TG concentration (see Chapter 2) . This relationship may reflect competition for a com-
mon clearance pathway between hepatic- and intestine-derived TG-rich fipoproteins (36) . Diminished 
postprandial fipemia and accelerated chylomicron-TG clearance might therefore be expected to occur 
in association with fasting hypotriglyceridemia in endurance-trained men. 
The purpose of the present study was to evaluate this hypothesis, and to Investigate the relationship 
between fasting and postprandial serum TG concentrations in endurance-trained men. If the reduction 
in postprandial lipemia associated with chronic exercise is due solely to diminished fasting serum TG 
pool size, then chylomicron-TG clearance should be similar in men with similar fasting serum TG con-
centrations, regardless of exercise status. Conversely, if chronic exercise facilitates TG clearance by 
increasing the capacity of the TG removal system, then chylomicron-TG clearance would tend to be 
faster in endurance athletes than in sedentary meri with similar fasting serum TG concentrations. 
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METHODS: 
1) Subjects: 
Twenty nine normolipidemic male students who habitually performed at least one hour of vigorous 
exercise per day gave written informed consent for this study. All of these men competed regularly in 
running or triathlon events. Twenty nine control subjects matched for body weight and fasting serum 
TG concentration were selected from a larger group of sedentary, normolipidemic male medical stu-
dents. The control subjects performed less than one hour of exercise per week (see Table 13 for clini-
cal data). All subjects followed self-selected diets, and all had been weight stable for at least six months 
prior to the study. None of the subjects was obese (91 ), and none smoked or used any medication 
known to affect lipoprotein metabolism. 
2) Procedures: 
The endurance trained subjects followed their customary exercise regimens on the day before each 
test. 
a) Oral fat tolerance tests: 
Oral fat tolerance was measured in 30 subjects (15 athletes and 15 sedentary men) using a procedure 
described in Chapter 1. Each subject was tested twice, in order to determine the serum TG responses 
to both large and small fat loads. On one occasion, the test meal comprised 350ml cream (140g fat) 
and 5g chocolate flavouring. For the second test, 100ml cream (40g fat) and 5g chocolate flavouring 
were consumed. Water was added to increase the volume to 350ml. 
In 1 O of the sedentary subjects, a further oral fat tolerance test (350ml cream) was performed 12 hours 
after an acute bout of moderate intensity exercise lasting 1 hour. The exercise session comprised 15 
minutes treadmill running {10km/hr at O incline) , 30 minutes ergometer cycling (150W) and 15 minutes 
rowing. No rest periods were permitted between these modalities. 
b) Intravenous fat tolerance tests: 
Intravenous fat tolerance was measured in 11 athletes and 11 sedentary men using the procedure 
described in Chapter 1. 
c) Duodenal perfusion studies: 
Chylomicron-TG clearance was measured in 16 subjects (8 athletes and 8 sedentary men) using the 
duodenal perfusion method described in Chapter 1. The perfusate, comprising 1 OOg olive oil and 7g 
gum acacia per litre of water, was infused at a rate of 175mg fat/kg body weight/hour. Previous studies 
have indicated that TG ingested in this form is efficiently absorbed (92) . 
Twenty two subjects (11 athletes and 11 sedentary men) participated in both the oral and in the in-
travenous test procedures. Eight of these subjects (4 athletes and 4 sedentary men) participated in the 
oral, intravenous and the duodenal perfusion studies. 
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3) Analysis of data: 
Postprandial lipemia, lntralipid clearance (k2), and the half life (T1/2) of chylomicron-TG measured 
during the duodenal perfusion studies were calculated as described in Chapter 1. The mean values of 
all parameters were compared using an unpaired t-test (95). 
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RESULTS: 
The test procedures were well tolerated, although most subjects reported transient nausea after con-
suming 350ml cream. The mean values of all parameters are shown in Table 15. 
Table 15. Ages, body weights, fasting serum TG concentrations and parameters of chylomicron-
TG clearance in athletes and sedentary men matched according to fasting serum TG concentra-
tion. 
a) Oral fat tolerance: 
DOSE AGE BWT FTG PPL 
Ath. Sed. Ath. Sed. Ath. Sed. Ath. Sed. 
40g 26.±.4 22.±.2 72.±.6 73.±.10 65.±.27 74.±.18 133.±.59 232.±.134a 
140g 26.±.4 22.±.2 72.±.6 73.±.10 66.±.19 68.±.9 222.±.103 543.±.165a 
b) Intravenous fat tolerance: 
AGE BWT FTG k2 
Ath. Sed. Ath. Sed. Ath. Sed. Ath. Sed. 
24.±.3 22.±.3 70.±.8 75.±.10 73.±.19 79.±.14 5.4.±.1.2 4.3.±.0.8b 
c) Duodenal perfusion studies: 
AGE BWT FTG t1/2 
Ath. Sed. Ath. Sed. Ath. Sed. Ath. Sed. 
23.±3 21.±1 65.±5 70.±8 57.±14 61.±15 3.0_±0.8 4.0.±1 .0c 
Values are means.±.standard deviations. 
P values are a< 0.001, b < 0.01, and c < 0.05 
Abbreviations and units: BWT =bodyweight (kg), FTG =fasting serum TG concentration (mg/dL), 
PPL=postprandial lipemia (mg.dL"1.8hr), k2=fractional clearance rate of intralipid (% per minute), 
t1/2 = chylomicron-TG half life (minutes). 
a) Oral fat tolerance tests: 
Postprandial lipemia was significantly lower in athletes than in sedentary men, after both the large and 
the small fat meals. The shape of curve of serum TG concentrations plotted against time appeared to 
be similar in athletes and in sedentary men. In both groups, peak serum TG concentrations were general-
ly reached 4 hours after consumption of the large fat meal (see Figure 19), and between 2 and 4 hours 
after consumption of the small fat meal (see Figure 20). 
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Figure 20. Serum triglyceride responses to 40g fat ingestion in athletes(•) and in sedentary men~-
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Postprandial lipemia was slightly, but not significantly reduced by acute exercise in sedentary men 
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Figure 21 . Serum triglyceride responses of sedentary men to 120g fat ingestion before (e) and 
after • exercise. 
b) Intravenous fat tolerance test: 
lntrallpid clearance was significantly faster in athletes than in sedentary men (see Figure 22). In all 
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Figure 22. Serum optical density after lntralipid administration in athletes (e) and sedentary men (a) . 
Chapter 6. Exercise and postprandial lipemia 
c) Duodenal perfusion studies: 
70 
In all subjects, serum TG concentrations were increased during the duodenal perfusion procedure. 
The mean half-life of chylomicron-TG was shorter in athletes than in sedentary men (see Figure 23). 
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Figure 23. Serum triglyceride responses to duodenal fat perfusion in athletes (II) and in sedentary 
men(o) 
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DISCUSSION: 
The results of this study indicate that postprandial lipemia is lower in athletes than in sedentary men. 
The magnitude of postprandial lipemia was diminished in athletes both after large, and after small fat 
meals. Therefore it seems likely that for any given fat meal, postprandial lipemia will be lower in athletes 
than in sedentary men. Since men following a Western diet may spend up to three-quarters of each 
day in a postprandial state, and since the major flux of plasma TG occurs during this period, postpran-
dial plasma TG concentrations probably provide a better index of diurnal plasma TG transport than do 
fasting concentrations. Accordingly, the findings of this study suggest that chronic exercise will reduce 
diurnal plasma TG concentrations. 
Postprandial lipemia and chylomicron-TG clearance: 
In the present study, chylomicron-TG half life determined using the duodenal perfusion method of 
Grundy and Mok (37) was shorter in athletes than in sedentary men. This finding suggests that exer-
cise may diminish postprandial _lipemia by reducing the intravascular residence time of chylomicron-
TG. 
Two caveats need to be considered here: 
1) The duodenal perfusion method is based on the assumption that the rate of influx of chylomicron-
TG into the blood plasma is equal to the rate of duodenal perfusion. Therefore it is possible that the 
short chylomicron-TG half life measured in the athletes reflects impaired TG absorption rather than rapid 
clearance. 
2) The flow rate of the duodenal perfusion was standardized for body weight. Athletes have a greater 
plasma volume per unit body weight than do sedentary men (151) , therefore at a given rate of TG 
clearance, steady-state chylomicron-TG concentrations would be expected to be lower in athletes than 
· in sedentary men. · 
Since neither TG absorption nor plasma volume were measured in these subjects, it is possible that 
the low chylomicron-TG half life of the athletes in this study was an artifact of the measuring technique. 
To control for these confounding factors, the k2 of a bolus of artificial chylomicrons (lntralipid) ad-
ministered intravenously was determined. The results obtained using this method, which is independent 
of the absorptive processes and of plasma volume, were in agreement with the results of the duodenal 
perfusion method. These findings therefore provide further support for the hypothesis that chylomicron-
TG clearance is greater in athletes than in sedentary men. 
Mechanisms of increased chylomicron-TG clearance: 
Chylomicron-TG half life may be determined by fasting serum TG concentration, by the composition 
and nature of the chylomicrons, and by the capacity of the TG clearing system(s). The mean fasting 
serum TG concentration was lower in the sedentary men in this study than in a randomly selected group 
of normolipidemic sedentary men described previously (96). The mean values for postprandial lipemia 
and chylomicron-TG half life were also lower in the present group than in normolipidemic sedentary 
men in two previous studies (8,37). These findings are in agreement with a previous observation (30) 
that postprandial lipemia and chylomicron-TG half life are diminished in men with low fasting serum TG 
concentrations. The low chylomicron-TG half life of athletes may therefore be explained, at least in part, 
by low fasting serum TG concentrations. To control for variation due to fasting serum TG concentra-
tion, the athletes and sedentary men in this study were matched according to fasting serum TG con-
centration. After this procedure, chylomicron-TG clearance was still significantly lower in the athletes 
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than in the sedentary men. These results indicate that the effect of exercise on chylomlcron-TG half life 
is not entirely attributable to diminished fasting serum TG concentrations. 
To exclude variations due to chylomicron structure, the intravascular kinetics of an artificial fat emul-
sion (lntralipid) were examined in athletes and in sedentary men. In both groups, the curve of lntralipid 
disappearance appeared to be mono- exponential. but the fractional clearance rate was significantly 
greater in the athletes than in the sedentary men. Previous investigators have reported similar effects 
of chronic exercise on intravenous fat tolerance in cross-sectional (143) and longitudinal (150) studies. 
The low chylomicron-TG half life in athletes is therefore unlikely to be due to exercise-induced changes 
in chylomicron structure. 
Given these considerations, it seems most probable that the difference between the mean 
chylomicron-TG half life of the athletes and the sedentary men in the present study is due to a direct 
effect of exercise on the TG removal system(s). 
This hypothesis is consistent with the findings of several previous studies, which have shown increased 
activity of LPL, the rate-limiting enzyme for plasma TG removal , in postheparin plasma (152) , in adipose 
tissue (153), and in skeletal muscle (154). in endurance trained men. 
Effects of acute and chronic exercise: 
Previous studies (155, 156) have indicated that exercise performed after the ingestion of a fatty meal 
reduces the magnitude of postprandial lipemia. Therefore, it is possible that low chylomicron-TG half 
life is a consequence of acute exercise, rather than a metabolic adaptation to exercise training. Some 
investigators have sought to distinguish acute from chronic exercise effects by testing athletes after 
brief periods of abstinence from exercise (90,157). Since the metabolic changes associated with exer-
cise adaptation cannot be quantitatively distinguished from those which follow bouts of acute exercise, 
the duration of the "detraining" period used in those studies was arbitrarily determined. In the present 
study, the effect of a single bout of exercise (of 1 hour duration) performed 12 hours prior to oral fat 
tolerance testing was examined in 10 sedentary men. Postprandial lipemia was slightly, but not sig-
nificantly reduced by acute exercise. On the basis of these results, the athletes in this study were al-
lowed to continue their customary training regimes until 12 hours prior to each test. In addition, these 
data indicate that the Increased rate of chylomicron-TG clearance measured in the athletes in this study 
cannot be quantitatively induced in sedentary men by exposure to acute exercise. 
Self-selection bias: 
In cross-sectional comparisons of athletes and sedentary men, it is not possible to distinguish differen-
ces attributable to chronic exercise from those which arise as a consequence of self- selection. Wil-
liams et al (158) , have suggested that men who choose to take up running tend to have low fasting 
plasma TG concentrations prior to participation in the sport. The low postprandial lipemia and 
chylomicron-TG half life of the athletes in this study may therefore be a consequence of self selection, 
rather than an adaptation to chronic exercise. This possibility seems unlikely, however, as the effects 
of exercise training on fasting serum TG concentration (159), LPL activity (152) , postprandial lipemia 
(75) and intravenous fat tolerance (150) have also been observed in longitudinal studies. 
In summary, the following conclusions seem reasonable: 
i) For any given fat load, the magnitude of postprandial lipemia will tend to be lower In athletes than 
in sedentary men. 
ii) Chronic exercise training reduces postprandial lipemia more effectively than does acute exercise. 
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iii) The reduction in postprandial lipemia associated with endurance exercise adaptation is due to a 
decrease in chylomicron-TG half life, rather than to impaired fat absorption. 
iv) The low chylomicron-TG half life in athletes may be partly related to reduced competition from a 
diminished pool of endogenous TG-rich lipoproteins. This mechanism cannot fully account for the low 
chylomicron-TG half life in these men, however. The effects of exercise on chylomicron-TG half-life are 
therefore at least partly attributable to increased activity of the TG clearance system(s). 
GENERAL CONCLUSIONS 
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GENERAL CONCLUSIONS 
The experiments described in this thesis were designed to examine the possible roles of different 
nutrients and hormones in regulating plasma TG concentrations during the postprandial period. Al-
though the ingestion of fats and carbohydrates has been shown to elicit the release of hormones which 
are known to increase the activity of adipose tissue LPL in vitro, no evidence for acute postprandial in-
creases in the fractional rate of plasma TG clearance emerged from any of these studies. Incremental 
fat loads produced directly proportional responses in aggregate postprandial lipemia, indicating the 
absence of a fat-induced increase in the fraction of plasma TG cleared per unit time. The addition of 
protein, and of various carbohydrates including starch, glucose, fructose, and sucrose to standard fat 
meals failed to diminish aggregate postprandial serum TG concentrations. These findings were sup-
ported by the observation that neither protein nor glucose ingestion increased the rate of clearance of 
an artificial fat emulsion from plasma. Therefore it appears that the rate of clearance of TG from the 
plasma is not actively increased in response to' feeding in man. Postprandial TG kinetics in man are 
thus not entirely consistent with those which would be predicted from in vitro observations of adipocyte 
LPL activity, or from animal models such as the rat, or dog. 
Since postprandial plasma TG concentrations appear to be determined by the rate of chylomicron-
TG clearance, and since chylomicron-TG clearance does not appear to be actively stimulated by feed-
ing, the massive influx of chylomicron-TG into the circulation which occurs after the ingestion of a fat 
meal must be accommodated by passive increases in the absolute rate of chylomicron-TG clearance. 
In this model, the fraction of the plasma chylomicron-TG pool which is removed per unit time remains 
constant, and the absolute quantity of chylomicron-TG cleared from the plasma pool increases with in-
creasing chylomicron-TG concentration. Support for this contention is provided by the observation that 
i) aggregate postprandial lipemia increases in direct proportion with increasing dietary fat loads, ii) that 
the disappearance of an intravenous bolus of lntralipid approximates first order kinetics, and iii) that 
plasma TG concentrations reach new steady state values during duodenal perfusion. These data imply 
a large reserve capacity for plasma TG clearance. In terms of the classical enzyme kinetic theory of 
Michaelis and Menten (see Introduction), the plasma TG clearing reaction operates far below satura-
tion under physiological conditions during the postprandial phase. While it cannot be assumed that the 
relationship between plasma TG flux and concentration is entirely first order during this period, it ap-
pears that the reserve capacity of the clearing mechanism is large enough to prevent significant 
decreases in the fractional clearance rate of chylomicron-TG after fat feeding. 
Given these considerations, it seems likely that the magnitude of postprandial lipemia is largely deter-
mined by the amount and type of fat in the meal, by the basal activity of the plasma TG clearance sys-
tem, and to a lesser extent by the pool size of endogenous TG-rich lipoproteins. 
Indications for further work: 
The present studies have largely elucidated the role of dietary factors in the acute plasma TG respon-
ses to feeding. Several aspects of the intravascular metabolism of diet-derived triglycerides remain un-
resolved, however. Areas for further work include: 
i) The nature of the relationship between endogenous TG-rich lipoproteins and chylomicrons. Al-
though almost all Western men consume mixed diets which contain a substantial proportion of fat, the 
influence of fat ingestion on the synthesis rate, structure and subsequent intravascular kinetics of hepatic 
VLDL is unknown. The contribution of diet-derived TG to hepatic VLDL-TG during the postprandial 
period has not been studied. While it has been argued that chylomicron-TG are hydrolysed in extra-
hepatic tissues, the proportion of the resulting fatty acids which are subsequently taken up by the liver 
is not known. Further studies in which hepatic- and intestine-derived lipoproteins are distinguished using 
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non- exchangeable markers such as retinyl palmitate and apo B48 and B100 may help to resolve these 
questions. 
ii) The mechanism(s) responsible for the effects of fatty acid chain saturation on postprandial lipemia. 
This question is particularly interesting in the light of the well-known effects of chronic feeding of polyun-
saturated fats on plasma lipoproteins. While the most likely explanations are considered in Chapter 3, 
there is no definitive in vivo evidence for any of these hypotheses. The resolution of this question is 
limited by the difficulties inherent in determining rates of substrate transport under non steady-state 
conditions. One approach which may help to circumvent this obstacle would be to measure the turn-
over of hepatic-derived VLDL during a steady-state duodenal fat perfusion, when serum chylomicron-
and hepatic-TG concentrations appear to remain relatively constant. By varying the saturation of the 
fats in the perfusate, the effects of saturated and polyunsaturated fats on hepatic VLDL-TG production 
and turnover could be assessed. 
iii) The mechanism(s) underlying the effects of chronic exercise on postprandial lipemia and 
chylomicron-TG clearance. This question is also of considerable practical relevance, since endurance 
exercise appears to confer a degree of protection against coronary artery disease, an effect which may 
be mediated (at least in part) by alterations in lipoprotein metabolism. While it is generally accepted 
that lipoprotein lipase activity is increased in endurance athletes, the importance of other factors such 
as the hepatic response to fat ingestion is completely unknown. The methodology outlined in (ii) above 
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